Ask the Scholar
Document scope · 1 page
Scholar
Ask about this object, its catalog metadata, its source description, or the page inventory.
For page-specific OCR and visual context, open one of the page chats.
Scholar Source Context
Document identity
localId
26082192
label
HRC - 1996 Personal - N
core
doc
dtoType
document
citationUrl
pageCount
1
Source metadata
id
26082192
sourceUrl
contentType
document
title
HRC - 1996 Personal - N
citationUrl
collections
Records of the First Lady's Office (Clinton Administration)
Pam Cicetti's Subject Files
imageCount
1
hasImages
yes
source
import
hasTranscription
no
Source extras
naId
26082192
levelOfDescription
fileUnit
otherTitles
42-t-2124771-20140159S-006-002-2015
recordType
description
ocrSource
nara-archive
Single page context
seq
1
pageIndex
0
type
document
mediaId
6d862baaf3481eea
ocrText
Withdrawal/Redaction Sheet
Clinton Library
DOCUMENT NO.
SUBJECT/TITLE
DATE
RESTRICTION
AND TYPE
001a. letter
From: Hillary Clinton, To: Grace Cavert Nelson (1 page)
9/10/96
Personal Misfile
001b. letter
From: Grace Cavert Nelson, To: Hillary (1 page)
9/4/96
Personal Misfile
002a. letter
From: Hillary Clinton, To: Thomas Neuville (3 pages)
2/20/96
Personal Misfile
002b. email
From: Thomas Neuville, To: Ms. Rodham-Clinton (2 pages)
1/31/96
Personal Misfile
003. card
From: Ellen Johnson, To: Hillary (3 pages)
10/9/96
Personal Misfile
004. resume
Curriculum Vitae, Maria 1. New, M.D. [partial] (1 page)
5/28/96
b(6)
005. letter
From: Helen Walton, To: Hillary (2 pages)
Jan
Personal Misfile
006. letter
From: Hillary Clinton, To: Tom and Carol Nicklaus (2 pages)
5/31/96
Personal Misfile
COLLECTION:
Clinton Presidential Records
First Lady's Office
Pam Cicetti
OA/Box Number: 10598
FOLDER TITLE:
HRC - 1996 Personal - N
2014-0159-S
sb244
RESTRICTION CODES
Presidential Records Act - (44 U.S.C. 2204(a)]
Freedom of Information Act [5 U.S.C. 552(b)]
P1 National Security Classified Information |(a)(1) of the PRA|
b(1) National security classified information [(b)(1) of the FOIA]
P2 Relating to the appointment to Federal office [(a)(2) of the PRAJ
b(2) Release would disclose internal personnel rules and practices of
P3 Release would violate a Federal statute [(a)(3) of the PRA]
an agency |(b)(2) of the FOIA]
P4 Release would disclose trade secrets or confidential commercial or
b(3) Release would violate a Federal statute |(b)(3) of the FOIA]
financial information [(a)(4) of the PRA]
b(4) Release would disclose trade secrets or confidential or financial
P5 Release would disclose confidential advice between the President
information [(b)(4) of the FOIA]
and his advisors, or between such advisors [a)(5) of the PRA]
b(6) Release would constitute a clearly unwarranted invasion of
P6 Release would constitute a clearly unwarranted invasion of
personal privacy [(b)(6) of the FOIA]
personal privacy |(a)(6) of the PRA]
b(7) Release would disclose information compiled for law enforcement
purposes |(b)(7) of the FOIA]
C. Closed in accordance with restrictions contained in donor's deed
b(8) Release would disclose information concerning the regulation of
of gift.
financial institutions [(b)(8) of the FOIA]
PRM. Personal record misfile defined in accordance with 44 U.S.C.
b(9) Release would disclose geological or geophysical information
2201(3).
concerning wells [(b)(9) of the FOIA]
RR. Document will be reviewed upon request.
HRC - 1996 Personal - N
PHOTOCOPY
PRESERVATION
F
Susan Ness
30 July 96
Dear Hillary,
Only in the Clinton White
House could you bring together
in agreement on kid vid the
dashing duo of Fritts and Chanen!
Dr just goes to show that
children's television can
DETERMINED TO BE AN
ADMINISTRATIVE MARKING
INITIALS: SAB DATE: 11/15/13
indeed be entertaining as well
as educational!
Manks po much for all
of your support on this issue.
Once my two colleagues finally
u Set with the program" we will
have an order that works for
families, works for b 'casters,
and works for the FCC.
d miss you!
Warmess Susar refards,
PHOTOCOPY
PRESERVATION
Bethesda, Maryland 20814
5505 Devon Road
personal
mp. Hillary Rodham Clinton
The White House
Washing ton, DC. 20500- 2000
10/96
DETERMINED TO BE AN ADMINSTRATIVE
MARKING Per E.O. 12958 as amended, Sec. 3.3 (c)
Initials: ADB
Date 11/15/13
THE WHITE HOUSE
WASHINGTON
John S. Nolan. Esquire
Miller ! ' Chevalier
655-15th 87., N.W.
Suite 900
Washington, D.C. 20005.570
personal
Withdrawal/Redaction Marker
Clinton Library
DOCUMENT NO.
SUBJECT/TITLE
DATE
RESTRICTION
AND TYPE
001a. letter
From: Hillary Clinton, To: Grace Cavert Nelson (1 page)
9/10/96
Personal Misfile
COLLECTION:
Clinton Presidential Records
First Lady's Office
Pam Cicetti
OA/Box Number: 10598
FOLDER TITLE:
HRC - 1996 Personal - N
2014-0159-S
sb244
RESTRICTION CODES
Presidential Records Act - [44 U.S.C. 2204(a)]
Freedom of Information Act - 15 U.S.C. 552(b)]
P1 National Security Classified Information |(a)(1) of the PRA]
b(1) National security classified information [(b)(1) of the FOIA]
P2 Relating to the appointment to Federal office [(a)(2) of the PRA|
b(2) Release would disclose internal personnel rules and practices of
P3 Release would violate a Federal statute [(a)(3) of the PRA]
an agency |(b)(2) of the FOIA]
P4 Release would disclose trade secrets or confidential commercial or
b(3) Release would violate a Federal statute [(b)(3) of the FOIA]
financial information |(a)(4) of the PRA]
b(4) Release would disclose trade secrets or confidential or financial
P5 Release would disclose confidential advice between the President
information [(b)(4) of the FOIA]
and his advisors, or between such advisors |a)(5) of the PRA]
b(6) Release would constitute a clearly unwarranted invasion of
P6 Release would constitute a clearly unwarranted invasion of
personal privacy [(b)(6) of the FOIA]
personal privacy [(a)(6) of the PRA]
b(7) Release would disclose information compiled for law enforcement
purposes [(b)(7) of the FOIA]
C. Closed in accordance with restrictions contained in donor's deed
b(8) Release would disclose information concerning the regulation of
of gift.
financial institutions |(b)(8) of the FOIA]
PRM. Personal record misfile defined in accordance with 44 U.S.C.
b(9) Release would disclose geological or geophysical information
2201(3).
concerning wells |(b)(9) of the FOIA]
RR. Document will be reviewed upon request.
Withdrawal/Redaction Marker
Clinton Library
DOCUMENT NO.
SUBJECT/TITLE
DATE
RESTRICTION
AND TYPE
001b. letter
From: Grace Cavert Nelson, To: Hillary (1 page)
9/4/96
Personal Misfile
COLLECTION:
Clinton Presidential Records
First Lady's Office
Pam Cicetti
OA/Box Number: 10598
FOLDER TITLE:
HRC - 1996 Personal - N
2014-0159-S
sb244
RESTRICTION CODES
Presidential Records Act |44 U.S.C. 2204(a)]
Freedom of Information Act - 15 U.S.C. 552(b)|
P1 National Security Classified Information [(a)(1) of the PRA|
b(1) National security classified information [(b)(1) of the FOIA]
P2 Relating to the appointment to Federal office [(a)(2) of the PRA|
b(2) Release would disclose internal personnel rules and practices of
P3 Release would violate a Federal statute |(a)(3) of the PRA|
an agency [(b)(2) of the FOIA]
P4 Release would disclose trade secrets or confidential commercial or
b(3) Release would violate a Federal statute |(b)(3) of the FOIA]
financial information [(a)(4) of the PRA]
b(4) Release would disclose trade secrets or confidential or financial
P5 Release would disclose confidential advice between the President
information [(b)(4) of the FOIA]
and his advisors, or between such advisors [a)(5) of the PRA|
b(6) Release would constitute a clearly unwarranted invasion of
P6 Release would constitute a clearly unwarranted invasion of
personal privacy [(b)(6) of the FOIA]
personal privacy |(a)(6) of the PRA]
b(7) Release would disclose information compiled for law enforcement
purposes [(b)(7) of the FOIA]
C. Closed in accordance with restrictions contained in donor's deed
b(8) Release would disclose information concerning the regulation of
of gift.
financial institutions |(b)(8) of the FOIA]
PRM. Personal record misfile defined in accordance with 44 U.S.C.
b(9) Release would disclose geological or geophysical information
2201(3).
concerning wells |(b)(9) of the FOIA]
RR. Document will be reviewed upon request.
Withdrawal/Redaction Marker
Clinton Library
DOCUMENT NO.
SUBJECT/TITLE
DATE
RESTRICTION
AND TYPE
002a. letter
From: Hillary Clinton, To: Thomas Neuville (3 pages)
2/20/96
Personal Misfile
COLLECTION:
Clinton Presidential Records
First Lady's Office
Pam Cicetti
OA/Box Number: 10598
FOLDER TITLE:
HRC - 1996 Personal - N
2014-0159-S
sb244
RESTRICTION CODES
Presidential Records Act - |44 U.S.C. 2204(a)|
Freedom of Information Act - [5 U.S.C. 552(b)]
P1 National Security Classified Information |(a)(1) of the PRAJ
b(1) National security classified information |(b)(1) of the FOIA]
P2 Relating to the appointment to Federal office [(a)(2) of the PRA]
h(2) Release would disclose internal personnel rules and practices of
P3 Release would violate a Federal statute ((a)(3) of the PRA|
an agency [(b)(2) of the FOIA]
P4 Release would disclose trade secrets or confidential commercial or
b(3) Release would violate a Federal statute |(b)(3) of the FOIA]
financial information [(a)(4) of the PRA
b(4) Release would disclose trade secrets or confidential or financial
P5 Release would disclose confidential advice between the President
information [(b)(4) of the FOIA]
and his advisors, or between such advisors |a)(5) of the PRA]
b(6) Release would constitute a clearly unwarranted invasion of
P6 Release would constitute a clearly unwarranted invasion of
personal privacy |(b)(6) of the FOIA]
personal privacy [(a)(6) of the PRA|
b(7) Release would disclose information compiled for law enforcement
purposes |(b)(7) of the FOIA]
C. Closed in accordance with restrictions contained in donor's deed
b(8) Release would disclose information concerning the regulation of
of gift.
financial institutions [(b)(8) of the FOIA]
PRM. Personal record misfile defined in accordance with 44 U.S.C.
b(9) Release would disclose geological or geophysical information
2201(3).
concerning wells [(b)(9) of the FOIA]
RR. Document will be reviewed upon request.
Withdrawal/Redaction Marker
Clinton Library
DOCUMENT NO.
SUBJECT/TITLE
DATE
RESTRICTION
AND TYPE
002b. email
From: Thomas Neuville, To: Ms. Rodham-Clinton (2 pages)
1/31/96
Personal Misfile
COLLECTION:
Clinton Presidential Records
First Lady's Office
Pam Cicetti
OA/Box Number: 10598
FOLDER TITLE:
HRC - 1996 Personal - N
2014-0159-S
sb244
RESTRICTION CODES
Presidential Records Act - |44 U.S.C. 2204(a)]
Freedom of Information Act - [5 U.S.C. 552(b)]
P1 National Security Classified Information |(a)(1) of the PRA
b(1) National security classified information |(b)(1) of the FOIA]
P2 Relating to the appointment to Federal office ((a)(2) of the PRAJ
b(2) Release would disclose internal personnel rules and practices of
P3 Release would violate a Federal statute |(a)(3) of the PRA|
an agency [(b)(2) of the FOIA|
P4 Release would disclose trade secrets or confidential commercial or
b(3) Release would violate a Federal statute |(b)(3) of the FOIA]
financial information [(a)(4) of the PRA]
b(4) Release would disclose trade secrets or confidential or financial
P5 Release would disclose confidential advice between the President
information |(b)(4) of the FOIA]
and his advisors, or between such advisors [a)(5) of the PRA]
b(6) Release would constitute a clearly unwarranted invasion of
P6 Release would constitute a clearly unwarranted invasion of
personal privacy [(b)(6) of the FOIA]
personal privacy [(a)(6) of the PRA]
b(7) Release would disclose information compiled for law enforcement
purposes [(b)(7) of the FOIA]
C. Closed in accordance with restrictions contained in donor's deed
b(8) Release would disclose information concerning the regulation of
of gift.
financial institutions |(b)(8) of the FOIA]
PRM. Personal record misfile defined in accordance with 44 U.S.C.
b(9) Release would disclose geological or geophysical information
2201(3).
concerning wells |(b)(9) of the FOIA]
RR. Document will be reviewed upon request.
Withdrawal/Redaction Marker
Clinton Library
DOCUMENT NO.
SUBJECT/TITLE
DATE
RESTRICTION
AND TYPE
003. card
From: Ellen Johnson, To: Hillary (3 pages)
10/9/96
Personal Misfile
COLLECTION:
Clinton Presidential Records
First Lady's Office
Pam Cicetti
OA/Box Number: 10598
FOLDER TITLE:
HRC - 1996 Personal - N
2014-0159-S
sb244
RESTRICTION CODES
Presidential Records Act |44 U.S.C. 2204(a)]
Freedom of Information Act 15 U.S.C. 552(b)|
P1 National Security Classified Information |(a)(1) of the PRA]
b(1) National security classified information |(b)(1) of the FOIA]
P2 Relating to the appointment to Federal office |(a)(2) of the PRA
b(2) Release would disclose internal personnel rules and practices of
P3 Release would violate a Federal statute |(a)(3) of the PRA]
an agency [(b)(2) of the FOIA]
P4 Release would disclose trade secrets or confidential commercial or
h(3) Release would violate a Federal statute |(b)(3) of the FOIA]
financial information [(a)(4) of the PRAJ
b(4) Release would disclose trade secrets or confidential or financial
P5 Release would disclose confidential advice between the President
information [(b)(4) of the FOIA]
and his advisors, or between such advisors [a)(5) of the PRA|
b(6) Release would constitute a clearly unwarranted invasion of
P6 Release would constitute a clearly unwarranted invasion of
personal privacy [(b)(6) of the FOIA]
personal privacy |(a)(6) of the PRA]
b(7) Release would disclose information compiled for law enforcement
purposes [(b)(7) of the FOIA]
C. Closed in accordance with restrictions contained in donor's deed
b(8) Release would disclose information concerning the regulation of
of gift.
financial institutions [(b)(8) of the FOIA]
PRM. Personal record misfile defined in accordance with 44 U.S.C.
b(9) Release would disclose geological or geophysical information
2201(3).
concerning wells |(b)(9) of the FOIA]
RR. Document will be reviewed upon request.
THE WHITE HOUSE
November 8, 1996
Maria I. New, M.D.
Professor and Chairman
Department of Pediatrics
The New York Hospital
Room N-237
525 East 68th Street
New York, New York 10021
Dear Dr. New:
Thank you for your letter, vitae, and thoughts on
pediatric health policy. I enjoyed visiting with you in New
York and appreciate your generous offer of assistance on
programs benefitting our nation's children. A member of
my staff will be calling to discuss these issues further.
With best regards, I am
Sincerely yours,
Hillary Hillary Rodham Rodbam Clinton Clinton
cc:
Chris Jennings
Office of Policy Development
DETERMINED TO BE AN ADMINSTRATIVE
MARKING Per E.O. 12958 as amended, Sec. 3.3 (c)
Initials: ADB
Date 11/15/13
Chirs followed up
PHOTOCOPY
HRC HANDWRITING
THE WHITE HOUSE
November 8, 1996
are " her we I her anysitis
Chris to will
Maria I. New, M.D.
Professor and Chairman
Department of Pediatrics
The New York Hospital
Room N-237
525 East 68th Street
New York, New York 10021
A stayl to
my be been these
Dear Dr. New:
discuss is
Thank you for your letter, vitae, and thoughts on
further
pediatric health policy. I enjoyed visiting with you in New
York and appreciate your generous offer of assistance on
programs benefitting our nation's children. A copy of your
letter and vitae have been forwarded to the Office of
Presidential Personnel for consideration
With best regards, I am
Sincerely yours,
Hillary Hillary Rodham Rodham Clinton Cliniton
cc:
Bob Nash
Office of Presidential Personnel
525 EAST 68th STREET NEW YORK, N.Y. 10021
THE NEW YORK HOSPITAL-CORNELL MEDICAL CENTER
OFFICE OF THE CHAIRMAN
DEPARTMENT OF PEDIATRICS
ROOM N-237
October 29, 1996
Mrs. Hillary Clinton
c/o Ms. Pam Cicetti
Office of the First Lady
Washington, DC 20500
Dear Mrs. Clinton:
As I am a devoted supporter of you and President Clinton, it was a pleasure
to meet you last night at the River Club in New York, and to hear your comments.
As I mentioned last night, I am very willing to devote time and energy to
help you develop more and better programs to benefit children. I am enclosing
for your reference my curriculum vitae in which you will note that I have long
been an advocate of children; and, as Chairman of Pediatrics at The New York
Hospital-Cornell Medical Center, I have the requisite experience and expertise in
research to be of help to you.
Specifically, I am willing to help you and the Administration in the
following problems:
a.
Promotion of children's health through research. Very few NIH
grants are awarded to pediatricians. This results from the training
requirements in Pediatrics which emphasize primary care and clinical
pediatrics. Yet, the NIH grants are awarded for excellence in
research in which pediatricians receive little or no training. Also the
study sections that review research grants consist mainly of basic
scientists with no clinical experience. Unless a reviewer has worked
with pediatric patients and realizes how difficult clinical research
can be, it is unlikely that a grant to do clinical research will receive
a high score.
b.
Increasing the opportunities for pediatric clinical research.
I applaud the Federal government's support of the Clinical Research
Centers Program at the NIH. Although strides are being made to
UNIVERS
CORNELL
LE
LZRA
promote clinical research as distinguished from basic research, very
little clinical research is being funded in pediatrics. The small
number of Childrens Clinical Research Centers is emblematic of this.
This stems from the training problem listed in "a." We can change
this. Research is the hope for the future--and our children are our
future.
C.
Alter the system for testing drugs intended for children.
The FDA tests drugs in ways that are suitable for adults, then the
dose is scaled down for children based on weight or surface area.
Drugs are not tested in young animals in preparation for treating
children. This is the wrong approach. Children are not small adults--
they have a different metabolism. Indeed, a dose may have to be
larger for children than for adults if the children metabolize the drug
faster. The FDA has recognized this problem--the system for drug
evaluation should be changed.
I very much look forward to hearing from you in the near future. I am happy
to help you by not only sharing my ideas with you but working on execution of
ideas that you consider worthy.
At this writing I am looking forward to President Clinton's re-election.
Mearia Sincerely, kew
Maria I. New, M.D.
Professor and Chairman
Department of Pediatrics
Chief, Pediatric Endocrinology
Harold and Percy Uris Professor of Endocrinology and Metabolism
Withdrawal/Redaction Marker
Clinton Library
DOCUMENT NO.
SUBJECT/TITLE
DATE
RESTRICTION
AND TYPE
004. resume
Curriculum Vitae, Maria I. New, M.D. [partial] (1 page)
5/28/96
b(6)
COLLECTION:
Clinton Presidential Records
First Lady's Office
Pam Cicetti
OA/Box Number: 10598
FOLDER TITLE:
HRC - 1996 Personal - N
2014-0159-S
sb244
RESTRICTION CODES
Presidential Records Act - [44 U.S.C. 2204(a)]
Freedom of Information Act - 15 U.S.C. 552(b)|
P1 National Security Classified Information |(a)(1) of the PRAJ
b(1) National security classified information [(b)(1) of the FOIA]
P2 Relating to the appointment to Federal office |(a)(2) of the PRA]
b(2) Release would disclose internal personnel rules and practices of
P3 Release would violate a Federal statute [(a)(3) of the PRA]
an agency |(b)(2) of the FOIA]
P4 Release would disclose trade secrets or confidential commercial or
b(3) Release would violate a Federal statute [(b)(3) of the FOIA]
financial information |(a)(4) of the PRA|
b(4) Release would disclose trade secrets or confidential or financial
P5 Release would disclose confidential advice between the President
information [(b)(4) of the FOIA]
and his advisors, or between such advisors |a)(5) of the PRAJ
b(6) Release would constitute a clearly unwarranted invasion of
P6 Release would constitute a clearly unwarranted invasion of
personal privacy |(b)(6) of the FOIA]
personal privacy |(a)(6) of the PRA|
b(7) Release would disclose information compiled for law enforcement
purposes [(b)(7) of the FOIA]
C. Closed in accordance with restrictions contained in donor's deed
b(8) Release would disclose information concerning the regulation of
of gift.
financial institutions [(b)(8) of the FOIA]
PRM. Personal record misfile defined in accordance with 44 U.S.C.
b(9) Release would disclose geological or geophysical information
2201(3).
concerning wells [(b)(9) of the FOIA]
RR. Document will be reviewed upon request.
CURRICULUM VITAE
Maria I. New, M.D.
Address:
The New York Hospital - Cornell Medical Center
525 East 68th Street
New York, New York 10021
Telephone No:
(212) 746-3450, 3456 FAX (212) 746-0300
Soc Sec No:
(b)(6)
004
Education:
1946-1950
B.A. - Cornell University, Ithaca, New York
1950-1954
M.D. - University of Pennsylvania School of Medicine,
Philadelphia, Pennsylvania
Post-Graduate Clinical and Research Training:
1954-1955
Internship in Medicine, Bellevue Hospital (3rd Division), New
York
1955-1957
Residency in Pediatrics, The New York Hospital, New York
1957-1958
Fellowship, National Institutes of Health, Research in
biochemistry and renal function, Department of Pediatrics; Dr.
Norman Kretchmer, sponsor; The New York Hospital-Cornell Medical
Center, New York
1958-1961
Research Pediatrician to the Diabetic Study Group of the
Comprehensive Care Teaching Program, The New York
Hospital-Cornell Medical Center, New York
1961-1964
Fellowship, National Institutes of Health, Research in the study
of specific hormone production of the adrenal and gonads during
childhood and adolescence and in diseased states; Department of
Medicine; Dr. R.E. Peterson, sponsor; The New York
Hospital-Cornell Medical Center, New York
Academic Appointments:
-1980-
Chairman, Department of Pediatrics, Cornell University Medical
College, New York
1971-
Professor of Pediatrics, Cornell University Medical College
1978-
Harold and Percy Uris Professor of Pediatric Endocrinology and
Metabolism, Cornell University Medical College
1974-1980
Vice Chairman, Department of Pediatrics, Cornell University
Medical College
1968-1971
Associate Professor of Pediatrics with tenure, Cornell University
Medical College
5/28/96
1
Academic Appointments (continued):
1963-1968
Assistant Professor of Pediatrics, Cornell University Medical
College
1958-1963
Instructor, Department of Pediatrics, Cornell University Medical
College
1964-
Division Head, Pediatric Endocrinology, Department of Pediatrics,
Cornell University Medical College
1981-
Professor, Adjunct Faculty, The Rockefeller University, NY
1984-1989
Associate Program Director, Pediatric Clinical Research Center,
Cornell University Medical College
1983-1984
Program Director, Pediatric Clinical Research Center, Cornell
University Medical College
1980-1983
Associate Program Director, Pediatric Clinical Research Center,
Cornell University Medical College
1968-1980
Director, Pediatric Clinical Research Center, Cornell University
Medical College
1966-1968
Assistant Program Director, Clinical Research Center, Cornell
University Medical College
Hospital Appointments:
1980-
Pediatrician-in-Chief, Department of Pediatrics, The New York
Hospital
1971-
Attending Pediatrician, with private patient privileges,
Department of Pediatrics, The New York Hospital
1968-1971
Associate Attending Pediatrician with private patient privileges,
Department of Pediatrics, The New York Hospital
1963-1967
Assistant Attending Pediatrician with private patient privileges,
Department of Pediatrics, The New York Hospital
1960-1963
Pediatrician to Out-Patients, Department of Pediatrics, The New
York Hospital
1957-1959
Assistant Pediatrician to Out-Patients, Department of Pediatrics,
The New York Hospital
1964-
Director, Pediatric Metabolism Clinic, Outpatient Department, The
New York Hospital
1973-
Visiting Physician, Rockefeller University Hospital, New York
1993-
Consultant, Memorial Sloan-Kettering Cancer Center
1993-
Consultant, Memorial Hospital for Cancer and Allied Diseases
1979-1993
Adjunct Attending Pediatrician, Department of Pediatrics,
Memorial Sloan-Kettering Cancer Center, New York
1992-
Honorary Member of the Pediatric Department, Blythedale
Children's Hospital, Valhalla, New York
1982-
Consultant, Department of Pediatrics, North Shore University
Hospital, Manhasset, New York
1986-
Consultant, Department of Pediatrics, Catholic Medical Center of
Brooklyn and Queens
1977-
Consultant, Pediatrics/Endocrinology: United Hospital, Port
Chester, New York
1974-1976
Consultant, Albert Einstein College of Medicine, Lincoln
Hospital, Bronx, New York
5/28/96
2
Memberships and Other Appointments:
1996
Member, National Academy of Sciences
1996-2000
Member, National Advisory Research Resources Council of the
National Institutes of Health, Dept of Health and Human Services
1994-
Member, Food and Drug Administration's Endocrine and Metabolic
Drug Advisory Committee
1994-2000
Panel Member, Board of Appeals/Pediatric Endocrinology, ACGME
1993
Member, The New York Academy of Sciences
1993
Member, Glucocorticoid-Remediable Aldosteronism" Registry.
1992
Elected Member, American Clinical and Climatologic Association
1992
Member, Century Club
1991-1997
Member, Research Advisory Committee of the Population Council
Center for Biomedical Research
1991
Member, Cosmopolitan Club
1991
Program Committee, International Endocrine Society
1990
Member, Association of American Physicians
1990
Member, The American Fertility Society
1990-1995
Elected member, US Pharmacopeial Convention
1989-
Board of Directors, The Laurentian Hormone Conference
1989-
Member, Career and Opportunities Committee, Am Acad of Pediatrics
1988-1992
Member, National Institutes of Health Reviewers Reserve
1988-1992
Member, Matilda Cuomo's Task Force on Child Abuse and Neglect
1988-1995
Member, The Mayor's Task Force on Child Abuse and Neglect
1985-
Panel Member, Governor's Task Force on Life and Law
1985
Panel Member, Consensus Conference on Obesity, NIH
1985
Panel Member, NIH, NIEHS Symposium on Estrogens in the
Environment
1985
Panel Member, Committee to Assess Premature Thelarche in Puerto
Rico, USPHS Centers for Disease Control, USPHS
1983-
National Advisory Committee, Robert Wood Johnson Minority Medical
Faculty Development Program
1983-
Committee on Medicine in Society, New York Academy of Medicine
1981-
Board of Directors, Robert Wood Johnson Clinical Scholars Program
1980-
Board of Directors, National Genetics Foundation
1976-
Member, Women's Caucus, The Endocrine Society
1975-
Senior Medical Consultant, Department of Health, City of New
York, Bureau of Handicapped Children
1961-
Fellow, Clinical Society, New York Diabetes Association
1987-1988
Chairperson, General Clinical Research Centers Advisory
Committee, Division of Research Resources, USPHS, NIH
1985-1986
Public Affairs Committee, The Endocrine Society
1985-1986
Member, Physician Advisory Panel, Burson-Marsteller Public
Relations
1984-1988
Member, General Clinical Research Centers Advisory Committee,
Division of Research Resources, USPHS, NIH
1981-1984
Council Member, The Endocrine Society
1981-1982
Referee, Macy Faculty Scholar Award Program
1980-1986
Board of Directors, The Harkness Ballet Foundation
1980-1982
Prenatal Committee of the Governor's Conference on the Prevention
of Developmental Disabilities and Infant Mortality, New York
State
5/28/96
3
Memberships and Other Appointments (continued):
1978-1979
Chairman, Awards Committee, The Endocrine Society
1977
Organizing Chairperson, Kroc Foundation, "Estrogen Treatment of
the Young"
1977-1988
Association of Program Directors, General Clinical Research
Centers
1977-1980
Endocrinology Study Section, National Institutes of Health
1976-1979
Program Committee, The Lawson Wilkins Pediatric Endocrine Society
(Chairman, 1979)
1976-1979
Ad Hoc Committee on Estrogen and Cancer, The tawson Wilkins
Pediatric Endocrine Society (Chairman, 1979)
1976-1979
Committee on Drugs, American Academy of Pediatrics
1976-1979
Chairperson, Juvenile Hypertension Subgroup of the Hypertension
Task Force, National Institutes of Health
1976-1978
Member, Awards Committee, The Endocrine Society
1975-1983
The New York State Health Research Council
1975-1986
Scientific Advisory Committee, The Irma T. Hirschl Trust
1973-1976
Membership Committee, The Lawson Wilkins Pediatric Endocrine
Society
1973-1974
Clinical Society Council, New York Diabetes Association
1973-1974
Clinical Standards Committee, New York Diabetes Association
1972-1980
Program and Symposium Committee, New York Diabetes Association
1970-1978
Medical Administration Committee of Camp NYDA, New York Diabetes
Association
1966-1975
Career Scientist, New York City Health Research Council
1962-1974
Trustee, Foundation for International Child Health
1958-1962
Coordinator, Speech and Hearing Program, Bureau of Handicapped
Children, City of New York
The New York Hospital-Cornell Medical Center Committees:
1992-1994
Member, Executive Faculty Council Appeal Board
1991-1993
Secretary, Medical Board, The New York Hospital
1982-
Charles H. Revson Fellowships in Biomedical Research, and Norman
and Rosita Winston Fellowships in Biomedical Research Review
Committee
1981-
Interinstitutional M.D.-Ph.D. Committee
1980-
Executive Faculty Council
1980-
Co-Chairperson, Clinical Services Task Force
1980-
Executive Committee of the Medical Board
1979-
Wage and Salary Policy Committee
1978-
Chairman, Liaison Committee on Medical Education
1977-
Committee of Review
1977-1980
Biomedical Research Support Grant Review Committee
1975-
Committee on Laboratories
1975-1979
Personnel Advisory Committee
Joint Administrative Board, Fund-Raising Committee
1973-
Ex officio Member, Scientific Advisory Committee
5/28/96
4
Professional Affiliations:
American Academy of Pediatrics
American Association for the Advancement of Science
American Association of Women in Science
American Board of Pediatrics
American College of Clinical Pharmacology
American Diabetes Association
American Federation for Clinical Research
American Pediatric Society
American Society of Andrology
American Society of Human Genetics
American Society of Nephrology
American Society of Pediatric Nephrology
American Society for Reproductive Medicine
Association of Medical Schools Pediatric Department Chairmen
Council for High:Blood Pressure Research (American Heart Association, Fellow)
The Endocrine Society
European Society for Pediatric Research
The Harvey Society
Inter-American Society of Hypertension
International Study Group of Diabetes in Children and Adolescents
International Study Group for Steroid Hormones
The Italian Endocrine Society
The Lawson Wilkins Pediatric Endocrine Society
New York Academy of Medicine (Fellow)
New York Academy of Sciences (Fellow)
New York Diabetes Association
New York Medical School Pediatric Department Chairmen
Pan American Medical Association
The Society for Pediatric Research
Awards and Honors:
1996
Basic Science Award, The Soc for the Advancement of Women's Health
Research
1996
Elected Member, National Academy of Science
1995
Rhône-Poulenc Rorer Clinical Investigator Lecture Award
1995
1996 British Endocrine Society for Endocrinology Dale Medal
1994
1994 Humanitarian Award, Juvenile Diabetes Foundation
1994
Recipient: Maurice R. Greenberg Distinguished Service_Award
1994
Honoree, National Organization of Italian-American Women.
1992
Elected Fellow, The American Academy of Arts and Sciences
1992
President, The Endocrine Society
1991
Recipient: Society of the Optimate Recognition Award
1991
Recipient: The New York Academy of Medicine Medal of Award
1991
Recipient: University of Pennsylvania School of Medicine
Distinguished Graduate Award
1990
President Elect, The Endocrine Society
1990
Member, President's Council of Cornell Women
1990
Recipient: Cardiovascular Reviews and Reports Master Teacher Classic
Award
1990
The C.D. Christian Distinguished Guest Lecturer, Society Gynecologic
Investigation Annual Meeting
1990
Recipient: Certificate of Appreciation, The Swedish Soc. of Medicine
6/19/96
5
Awards and Honors: (continued)
1990
Due Casé Award, International Partnership Program, Office of the
Governor of New York State
1989
Recipient: Barnard Centennial Award: "100 Outstanding New York
Women"
1988
Robert H. Williams Distinguished Leadership Award in Endocrinology
1988
Albion 0. Bernstein Award of the Medical Society of the State of New
York
1988
Outstanding Woman, Ladies' Home Journal
1988
Alpha Omega Alpha, Univ. Pennsylvania Sch. of Medicine
1986
Outstanding Woman Scientist, Metropolitan New York Chapter of
American Women in Science (AWIS)
1986
Honorary Fellow of the Italian Society of Endocrinology
1985-86
President, The Lawson Wilkins Pediatric Endocrine Society
1982
Close Encounters with Great Biomedical Scientists Series, Medical
Student Research Training Prgr, Univ. Arizona, Col of Medicine
1981
Katharine D. McCormick Distinguished Lectureship, Stanford
University School of Medicine
1981
John Fitzgerald Kennedy Memorial Lectureship of Georgetown
University
1977
Mary Jane Kugel Award, Juvenile Diabetes Foundation, New York
1972
AMITA Achievement Award for Medicine
Editorial Positions:
1994-99
Editor-in-Chief, Journal of Clinical Endocrinology and Metabolism
1995-
Editorial Advisory Council, Journal of Endocrinological
Investigation
1993
Editorial Board, Journal of Women's Health
1984-
Corresponding Editor, Journal of Steroid Biochemistry
1981-
Advisory Board, Pediatric Annals
Associate Editor, Metabolism
1973-80
Editorial Board, The Journal of Clinical Endocrinology and
Metabolism
Editorships
New MI and Fiser RH Jr (eds), Diabetes and Other Endocrine Disorders During
Pregnancy and in the Newborn. In: Progress in Clinical and Biological Research, Vol
10, Alan R. Liss Inc, New York, 1976.
New MI and Levine LS (eds), Juvenile Hypertension, Kroc Foundation Series, Vol. 8,
Raven Press, New York, 1977.
Giovannelli G, New MI and Gorini S (eds), Hypertension in Children and Adolescents,
Raven Press, New York, 1981.
New MI and Levine LS (eds), Adrenal Diseases in Childhood, In: Z Laron (ed.),
Pediatric and Adolescent Endocrinology, Vol 13, S Karger AG, Basel, 1984.
5/28/96
6
New MI and Levine LS (eds), Congenital Adrenal Hyperplasia, In: F Gross, MM
Grumbach, A Labhart, MB Lipsett, T Mann, LT Samuels, and J Zander (eds), Monographs
on Endocrinology, Vol 26, Springer-Verlag, New York, 1984.
New MI (ed), Congenital Adrenal Hyperplasia, In: Annals of the New York Academy of
Sciences, Vol 458, The New York Academy of Sciences, New York, 1985.
Editorships (continued)
New MI and Borelli P (eds), Dexamethasone-Suppressible Hyperaldosteronism, Serono
Symposia Review No. 10, Ares-Serono Symposia, Rome, Italy, 1986.
Cavallo L, Chiumello G, Grant DB, New MI, Schettini F (eds), International
Symposium, Endocrine Involvement in Chronic Diseases in Children, Arti Grafiche
Defa, Milano, 1986, pp 119-125.
Cavallo L, Job JC, New MI (eds), Growth Disorders: The State of the Art, Serono
Symposia, vol. 81, Raven Press, New York, 1991.
Pintor C, Loche S, Muller EE, New MI, (eds), Proceedings of the International
Sardinian Congr. on Pediatric Endocrinology, Porto Cervo, Oct. 1990. In: Advances
in Pediatric Endocrinology, Springer Verlag, Berlin, 1992.
New MI (ed): Where Phenotype Does Not Match Genotype. In: Frontiers in
Endorcinology, vol. 16, Ares-Serona Symposia Series, Rome, 1966.
Isidori A, New MI, Sesma CP (eds), Molecular Basis of Endocrine Diseases,
International Symposium, Rome, November 18-19, 1993, In: Ares-Serona Symposia
Series-Frontiers in Endocrinology, vol 7, 1994.
Palfrey J, Schulman I, Katz SL, New MI: The Disney Encyclopedia of Baby and Child
Care, vols I, II, Hyperion, New York, 1995.
5/28/96
7
LIST OF PUBLICATIONS
1
MARIA I. NEW
1.
New MI, McNamara H, Kretchmer N: Accumulation of para-amino-hippurate by slices of
kidney from rabbits of various ages. Proc Soc Exp Biol Med 102:558-560, 1959.
2.
New MI, Roberts TN, Bierman EL, Reader GG: The significance of blood lipid alterations
in diabetes mellitus. Diabetes 12:208-212, 1963.
3.
New MI: Endocrine factors in growth. Medical Science 15:52-55, 1964.
4.
Bauer CH, New MI, Miller JM: Cerebrospinal fluid protein values of premature infants. J
Pediatr 6:1017-1022, 1965.
5.
New MI, Miller B, Peterson RE: Aldosterone excretion in normal children and in children
with adrenal hyperplasia. J Clin Invest 45:412-428,1966.
6.
New MI, Peterson RE: Disorders of aldosterone secretion in childhood. Pediatr Clin North
Am 13:43-58, 1966.
7.
Greenberg AJ, Arboit JM, New MI, Worthen HG: Normotensive secondary
hyperaldosteronism. J Pediatr 69:719-727, 1966.
8.
Bongiovanni AM, Eberlein WR, Goldman AS, New MI: Disorders of adrenal steroid
biogenesis. Rec Prog Horm Res 23:375-449, 1967.
9.
New MI, Peterson RE: A new form of congenital adrenal hyperplasia. J Clin Endocrinol
Metab 27:300-305, 1967.
10.
Grossman H, New MI: Precocious sexual development: Roentgenographic aspects. Am J
Roent Rad Ther Nucl Med_100:48-62, 1967.
11.
Nadler AC, Sonenberg M, New MI, Free CA: Growth hormone activity in man with
components of tryptic digests of bovine growth hormone. Metabolism 16:830-845, 1967.
12.
Curi JFJ, Vanucci RC, Grossman H, New MI: Elevated serum gonadotropins in Silver's
syndrome. Am J Dis Child 114:658-661, 1967.
13.
New MI, Peterson RE: Aldosterone in childhood, In Advances in Pediatrics, SZ Levine
(ed). Year Book Medical Publishers, Chicago, 15:111-136, 1968.
14.
New MI, Gross JM, Peterson RE: Double isotope dilution derivative technique for
testosterone glucuronoside in urine. Acta Endocrinologica 58:77-97, 1968.
15.
New MI: Congenital adrenal hyperplasia. Pediatric Clinics of North America 15:395-407,
1968.
5/28/96
LIST OF PUBLICATIONS
2
MARIA I. NEW
16.
New MI, Seaman MP, Peterson RE: A method for the simultaneous determination of the
secretion rates of cortisol, 11-desoxycortisol,corticosterone, 11-desoxycorticosterone and
aldosterone. J Clin Endocrinol Metab 29:514-522, 1969.
17.
Merkatz IR, New MI, Peterson RE, Seaman MP: Prenatal diagnosis of adrenogenital
syndrome by amniocentesis. J Pediatr 75:977-982, 1969.
18.
Simpson JL, Allen Jr FH, New MI, German J: Absence of close linkage between the locus
for Xg and the locus for anhidrotic ectodermal dysplasia. Vox Sang 17:465-467, 1969.
19.
New MI: Antenatal diagnosis of the adrenogenital syndrome (Letter to the Editor). Lancet
1:83, 1970.
20.
New MI, Seaman MP: Secretion rates of cortisol and aldosterone precursors in various
forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 30:361-371, 1970.
21.
New MI (with the technical assistance of Suvannakul L): Male pseudo- hermaphroditism
due to 17α-hydroxylase deficiency. J Clin Invest 49:1930-1941, 1970.
22.
New MI: Endocrinological disorders. Bull Sloane Hosp Women 16:91-99, 1970.
23.
New MI: Methods for the diagnosis of congenital adrenal hyperplasia. In: FW Sunderman
and FW Sunderman (eds), Laboratory Diagnosis of Endocrine Diseases. Warren H Green
Inc, St Louis, 1971, pp 517-524.
24.
Morillo-Cucci G, New MI, Simpson JL, Allen Jr FH, German J: Abnormalities of human sex
chromosomes III Duplication in the long arm of the Y chromosome (45,X/46,XYq+) in
Y-gonadal dysgenesis. Ann Genet 14:113-120, 1971.
25.
Levine LS, New MI: Preoperative detection of hidden testes, Am J Dis Child 121:176-178,
1971.
26.
Bullock LP, New MI: Testosterone and cortisol concentration in spermatic, adrenal and
systemic venous blood in adult male guinea pigs. Endocrinology 88:523-526, 1971.
27.
Simpson JL, New MI, Peterson RE, German J: Pseudovaginal perineoscrotal hypospadias
(PPSH) in sibs. In: Proceedings of the Third Conference on Clinical Delineation of Birth
Defects, VA McKusick (ed), In: Birth Defects: Original Article Series, vol 7, 1971, pp
140-144.
28.
New MI, Parks GA, Landey S, Wiedemann E: Dwarfism associated with defective sulfation
factor generation, Clin Res 19:378, 1971.
2/1/95
LIST OF PUBLICATIONS
3
MARIA 1. NEW
29.
Parks GA, Bermudez JA, Anast CS, Bongiovanni AM, New MI: Pubertal boy with the
3ß-hydroxysteroid dehydrogenase defect. J Clin Endocrinol Metab 33:269-278, 1971.
30.
Giombetti R, Hagstrom JWC, Landey S. Young MC, New MI: Cushing's syndrome in
infancy: a case complicated by monilial endocarditis. Am J Dis Child 122:264-266, 1971.
31.
Zachmann M, Vollmin JA, New MI, Curtius H-CH, Prader A: Congenital adrenal
hyperplasia due to deficiency of 11ß-hydroxylation of 17α-hydroxylated steroids. J Clin
Endocrinol Metab 33:501-508, 1971.
32.
Sonenberg M, Yamasaki N, Kikutani M, Swislocki NI, Levine LS, New MI: Studies on
active fragments of bovine growth hormone. In: A Pecile and EE Muller (eds), Growth and
Growth Hormone, In: Excerpta Medica International Congress Series, No 244. 1972, pp
75-90.
33.
Parks, GA, New MI, Bongiovanni AM, Bermudez JA, Anast CS: Puberty in a male with
3ß-ol-dehydrogenase deficiency. In: BB Saxena, CG Beling and HM Gandy (eds),
Gonadotropins, John Wiley and Sons, NY, 1972, pp 535-545.
34.
New MI, Schwartz E, Parks GA, Landey S, Wiedemann E: Pseudohypopituitary dwarfism
with normal plasma growth hormone and low serum sulfation factor. J Pediatr 80:620-626,
1972.
35.
Levine LS, New MI, Pitt P, Peterson RE: Androgen production in boys with sexual
precocity and congenital adrenal hyperplasia. Metabolism 21:457-464 1972.
36.
Shanies DD, Hirschhom K, New MI: Metabolism of testosterone by cultured human
cells. J Clin Invest 51:1459-1468, 1972.
37.
New MI: Adrenogenital syndrome. In: A Dorfman (ed), Antenatal Diagnosis, A University
of Chicago Press, Chicago, 1972, pp 153-160.
38.
Opitz JM, Simpson JL, Sarto GE, Summitt RL, New MI, German J: Pseudovaginal
perineoscrotal hypospadias. Clin Genet 3:1-26, 1971.
39.
New MI: Ambiguous genitalia. Ortho Panel, 16:2-5, 1973.
40.
Dahms WT, Gray G, Vrana M, New MI: Adrenocortical adenoma and
ganglioneuroblastoma in a child: A case presenting as Cushing syndrome with virilization.
Am J Dis Child 125:608-611, 1973.
41.
New MI, Siegal EJ, Peterson RE: Dexamethasone-suppressible hyperaldosteronism. J
Clin Endocrinol Metab 37:93-100, 1973.
42.
New MI, Levine LS: Congenital adrenal hyperplasia. In: H Harris and K Hirschhorn (eds),
Advances in Human Genetics, vol 4, Plenum Press, New York 1973, pp 251-326.
2/1/95
LIST OF PUBLICATIONS
4
MARIA I. NEW
43.
Levine LS, Sonenberg M, New MI: Metabolic effects in children of a 37 amino acid
fragment of bovine growth homone. J Clin Endocrinol Metab 37:607-615, 1973.
44.
Saenger P, Shanies DD, New MI: Influence of medroxyprogesteroneacetate on
testosterone metabolism by cultured human fibroblasts: A model for drug steroid
interaction. J Clin Endocrinol Metab 37:760-764, 1973.
45.
McCrory WW, New MI, Yaffe SJ: Drugs and the Unbom Child, sponsored by The National
Foundation-March of Dimes, March, 1973. Clin Pharmacol Therap 14(2), 1973.
46.
Sonenberg M, Levine LS, New MI, Saxena BB: Fragments of growth hormone, In: S Raiti
(ed), Advances in Human Growth Hormone Research, National Pituitary Agency, DHEW
Publication No (NIH) 74-612, 1973, pp 467-480.
47.
Parks GA, Dumars KW, Limbeck GA, Quinlivan WL, MI New: True agonadism: A
misnomer. J Pediatr 84:375-380, 1974.
N
48.
Saenger P, Wiedemann E, Schwartz E, Korth-Schutz S, Lewy JE, Riggio RR, Rubin AL,
Stenzel KH, New MI: Somatomedin and growth after renal transplantation, Pediatr Res
8:163-169, 1974.
49.
Korth-Schutz S, Levine LS, Merkatz IR, New MI: An unusual case of Cushing's syndrome,
Hilus cell tumor and polycystic ovaries. J Clin Endocrinol Metab 38:794-800, 1974.
50.
Bennett SP, Levine LS, Siegal EJ, Lewy JE, Susin M, Peterson RE, New MI: Juvenile
hypertension caused by overproduction of renin with in a renal segment. J Pediatr
84:689-695, 1974.
51.
Saenger P, Levine LS, Wiedemann E, Schwartz E, New MI: Growth with absent growth
hormone by radioimmunoassay (Letter to the Editor). J Pediatr 85:137-138, 1974.
52.
Parks GA, Korth-Schutz S, Penny R, Hilding RF, Dumars KW, Frasier SD, MI New:
Variation in pituitary-gonadal function in adolescent male homosexuals and heterosexuals.
J Clin Endocrinol Metab 39:796-801, 1974.
53.
Canale VC, Steinherz P, New MI, Erlandson M: Endocrine function in thalassemia major.
Ann NY Acad Sci 232:333-345, 1974.
54.
New MI, Levine LS: Congenital adrenal hyperplasia. Ped Annals 3:27-53, 1974.
55.
Rifkind AB, Bennett S, Forster ES, New MI: Components of the heme biosynthetic
pathway and mixed function oxidase activity in human fetal tissues. Biochem Pharmacol
24:839-846, 1975.
56.
Lewy JE, New MI: Growth in children with renal failure. Am J Med 58:65-68, 1975.
2/1/95
LIST OF PUBLICATIONS
5
MARIA I. NEW
57.
Dobeme Y, Levine LS, New MI: Elevated urinary testosterone andandrostanediol in
precocious adrenarche. Pediatr Res 9:794-797, 1975.
58.
Saenger P, Rifkind AB, New MI: Changes in drug metabolism in children with thyroid
disorders. J Clin Endocrinol Metab 42:155-159, 1976.
59.
Saenger P, Schwartz E, Wiedemann E, Levine LS, Tsai M, New MI: The interaction of
growth hormone, somatomedin and oestrogen in patients with Tumer's syndrome. Acta
Endocrinologica 81:9-18, 1976.
60.
Levine LS, Lewy JE, New MI: Hypertension in high school students: Evaluation in New
York City. NYS J Med 76:40-44, 1976.
61.
Korth-Schutz S, Levine LS, New MI (with the technical assistance of DM Chow), Serum
androgens in normal prepubertal and pubertal children and in children with precocious
adrenarche. J Clin Endocrinol Metab 42:117-124, 1976.
62.
Doberne Y, New MI: Urinary androstanediol and testosterone in adults. J Clin Endocrinol
Metab 42:152-154, 1976.
63.
Saenger P, Levine LS, Wiedemann E, Schwartz E, New MI: Somatomedin in cerebral
gigantism (Letter to the Editor). J Pediatr 88:155-156, 1976.
64.
New MI, Baum CJ, Levine LS: Nomograms relating aldosterone excretion to urinary
sodium and potassium in the pediatric population: Their application to the study of
childhood hypertension. Am J Cardiol 37:658-666, 1976.
65.
Korth-Schutz S, Levine LS, New MI (with the technical assistance of DM Chow), Evidence
for the adrenal source of androgens in precocious adrenarche. Acta Endocrinologica
82:342-352, 1976.
66.
Korth-Schutz S, Levine LS, New MI (with the technical assistance of DM Chow):
Dehydroepiandrosterone sulfate (DS) levels, a rapid test for abnormal adrenal androgen
secretion. J Clin Endocrinol Metab 42:1005-1013,1976.
67.
Wachtel SS, Koo GC, Breg WR, Thaler HT, Dillard GM, Rosenthal IM, Dosik H, Gerald
PS, Saenger P, New MI, Lieber E, Miller OJ: Serologic detection of a Y-linked gene in XX
males and XX true hermaphrodites. New Engl J Med 295:750-754, 1976.
68.
Saenger P, Levine LS, Wachtel SS, Korth-Schutz S. Dobeme Y, Koo GC, Lavengood Jr
RW, German III JL, New MI: Presence of H-Y antigen and testis in 46,XX true
hermaphroditism, evidence for Y-chromosomal function, J Clin Endocrinol Metab
43:1234-1239, 1976.
2/1/95
LIST OF PUBLICATIONS
6
MARIA I. NEW
69.
New MI, Peterson RE, Saenger P, Levine LS: Evidence for an unidentified ACTH-induced
steroid hormone causing hypertension. J Clin Endocrinol Metab 43:1283-1293, 1976.
70.
New MI: Prenatal diagnosis of congenital adrenal hyperplasia, In: MI New, RH Fiser Jr
(eds), Diabetes and Other Endocrine Disorders During Pregnancy and in the Newborn, In:
Progress in Clinical and Biological Research, vol 10, Alan R Liss, New York, 1976, pp
205-219.
71.
Rifkind AB, Canale V, New MI: Antipyrine clearance in homozygous ß-thalassemia. Clin
Pharm Therap 20:476-483, 1976.
72.
Korth-Schutz S, Levine LS, Roth JA, Saenger P, New MI: Virilizing adrenal tumor in a child
suppressed with dexamethasone for three years: Effect of o,p'-DDD on serum and urinary
androgens. J Clin Endocrinol Metab 44:433-439, 1977.
73.
New MI: Present status of prenatal diagnosis of congenital adrenal hyperplasia, In: PA
Lee, LP Plotnick, AA Kowarski and CJ Migeon (eds), Congenital Adrenal Hyperplasia,
University Park Press, Baltimore, 1977, pp 511-526.
74.
Levine LS, Korth-Schutz S, Saenger P, Sweeney III WJ, Beling CG, New MI: Disordered
puberty in treated congenital adrenal hyperplasia. In: PA Lee, LP Plotnick, AA Kowarski
and CJ Migeon (eds), Congenital Adrenal Hyperplasia, University Park Press, Baltimore,
1977, pp 361-378.
75.
Ulick S, Ramirez LC, New MI: An abnormality in steroid reductive metabolism in a
hypertensive syndrome. J Clin Endocrinol Metab 44:799-802, 1977.
76.
New MI, Levine LS, Biglieri EG, Pareira J, Ulick S: Evidence for an unidentified steroid in a
child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 44:924-933,
1977.
77.
New MI, Levine LS: Mineralocorticoid hypertension in childhood. Mayo Clin Proc
52:323-328, 1977.
78.
Koo GC, Wachtel SS, Saenger P, New MI, Dosik H, Amarose AP, Dorus E, Ventruto V:
H-Y antigen: Expression in human subjects with the testicular feminization syndrome.
Science 196:655-656, 1977.
79.
New MI, Levine LS: An unidentified ACTH-stimulable adrenal steroid in childhood
hypertension. In: MI New and LS Levine (eds), Juvenile Hypertension, Raven Press, New
York, 1977, pp 143-163.
80.
New MI: Prenatal diagnosis of congenital adrenal hyperplasia. In: HL Vallet and IH Porter
(eds), Genetic Mechanisms of Sexual Development, Academic Press, New York, 1979, pp
197-220.
2/1/95
LIST OF PUBLICATIONS
7
MARIA I. NEW
81.
Saenger P, Goldman AS, Levine LS, Korth-Schutz S, Muecke EC, Katsumata M, Dobeme
Y, New MI: Prepubertal diagnosis of steroid 5α-reductase deficiency. J Clin Endocrinol
Metab 46:627-634, 1978.
82.
Rosler A, Levine LS, Schneider B, Novogroder M, New MI: The interrelationship of sodium
balance, plasma renin activity and ACTH In congenital adrenal hyperplasia. J Clin
Endocrinol Metab 45:500-512, 1977.
83.
Saenger P, New MI: Inhibitory action of dehydroepiandrosterone (DHEA) in fibroblast
growth. Experientia 33:966-967, 1977.
84.
Saenger P, Levine LS, Wiedemann E, Schwartz E, Korth-Schutz S, Pareira J, Heinig B
and New MI: Somatomedin and growth hormone in psychosocial dwarfism. Padiatrie und
Padologie (suppl 5):1-12, 1977.
85.
New MI, Virdis R, Virdis P: Ipertensione ormonale dell'infanzia, Problemi Attuali in
Pediatria, 13-26, 1977.
86.
McVie R, Levine LS, New MI: The biologic significance of the aldosterone cortcentration in
saliva. Pediatr Res 13:755-759, 1979.
87.
Korth-Schutz S, Virdis R, Saenger P, Chow DM, Levine LS, New MI: Serum androgens as
a continuing index of adequacy of treatment of congenital adrenal hyperplasia. J Clin
Endocrinol Metab 46:452-458, 1978.
88.
Pang S, Hotchkiss J, Drash AL, Levine LS, New MI: Microfilter paper method for
17α-hydroxyprogesterone radioimmunoassay: Its application for rapid screening for
congenital adrenal hyperplasia. J Clin Endocrinol Metab 45:1003-1008, 1977.
89.
New MI, Rauh W: Childhood obesity and hypertension. In: E Cacciari, Z Laron, and S
Raiti (eds), Obesity in Childhood, Proceedings of the Serono Symposia, vol 17, Academic
Press, London, 1978, pp 87-90.
90.
Virdis R, Saenger P, Senior B, New MI: Endocrine studies in a pubertal male
pseudohermaphrodite with 17-ketosteroid reductase deficiency. Acta Endocrinologica
87:212-224, 1978.
91.
"New MI et al: Report of the Hypertension Task Force: Current Research and
Recommendations from the Task Force Subgroups on Pediatrics and Genetics, Volume 6;
DHEW Publication No (NIH) 79-1628, 1979.
92.
New MI: H-Y antigen and abnormal sex determination. In: OP Ghai (ed), New
Developments in Pediatric Research, Proceedings of the XV International Congress of
Pediatrics, Interprint, 1977, pp 1119-1120.
93.
New MI, Levine LS: Pathogenesis and endocrinological aspects of hypertension, In: OP
Ghai (ed), New Developments in Pediatric Research, Proceedings of the XV International
Congress of Pediatrics, Interprint, 1977, pp 61-669.
2/1/95
LIST OF PUBLICATIONS
8
MARIA I. NEW
94.
New MI, Levine LS: Adrenocortical hypertension. Pediatr Clin North Am 25:67-81, 1978.
95.
New MI: Ambiguous sex in the newbom: Genital anomalies. In: Perspectives on Sex and
Gender-A Multidisciplinary Conference, Institute for Urban and Minority Education, New
York, pp 18-20, 1979.
96.
New MI, Levine LS: An unidentified ACTH stimulable adrenal steroid in childhood
hypertension. In: G Chiumello and Z Laron (eds), Recent Progress in Pediatric
Endocrinology, Proceedings of the Serono Symposia, vol 12, Academic Press, New York,
1977. pp 249-267.
97.
Oberfield SE, Levine LS, Carey RM, Bejar R, New MI: Pseudohypoaldosteronism: Multiple
target organ unresponsiveness to mineralocorticoid hormones. J Clin Endocrinol Metab
48:228-234, 1979.
98.
Ferraris J, Saenger P, Levine LS, New MI, Pang S, Saxena BB, Lewy JE: Delayed puberty
in males with chronic renal failure. Kidney lot 18:344-350, 1980.
99.
New MI, Rauh W: Childhood obesity and hypertension. In: PJ Collipp (ed), Childhood
Obesity, 2nd edition, PSG Publishing Co, Mass, 1980, pp 57-61.
100. Rauh W, Levine LS, Gottesdiener K, New MI, Mineralocorticoids, salt balance and blood
pressure after prolonged ACTH administration in juvenile hypertension. Klin Wochenschr,
56(suppl I):161-167, 1978.
101. Levine LS, Novogroder M, Saxena B, Saenger P, Saito I, New MI: Primary intracranial
HCG-producing germinoma in a boy with congenital adrenal hyperplasia. Acta Endocrinol
88:122-131, 1978.
102. Levine LS, Zachmann M, New MI, Prader A, Pollack MS, O'Neill GJ, Yang SY, Oberfield
SE, Dupont B: Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA
linkage group. N Engl J Med 299:911-915, 1978.
103. New MI: Guidelines for screening and treating hypertensive children. Modem Med
46:36-45, 1978.
104. Pang S, Levine LS, Chow D, Sagiani F, Saenger P, New MI: Dihydrotestosterone and its
relationship to testosterone in infancy and childhood. J Clin Endocrinol Metab 48:821-826,
1979.
105. Pang S, Levine LS, Chow DM, Faiman C, New MI: Serum androgen concentrations in
neonates and young infants with congenital adrenal hyper- plasia due to 21-hydroxylase
deficiency. Clin Endocrinol 11:575-584, 1979.
106. Rauh W, Gottesdiener K, Chow D, Forster E, Saenger P, Levine LS, New MI: Aldosterone
response to prolonged ACTH infusion in juvenile hypertension. Pediatr Res
14:1035-39,1980.
2/1/95
LIST OF PUBLICATIONS
9
MARIA I. NEW
107. Voccia E, Saenger P, Peterson RE, Rauh W, Gottesdiener K, Levine LS, New MI: 6-Beta-
hydroxycortisol excretion in hypercortisolemic states. J Clin Endocrinol Metab
48:467-71,1979.
108. Lorenzen F, Pang S, New MI, Dupont B, Pollack M, Chow DM, Levine LS: Hormonal
phenotype and HLA-genotype in families of patients with congenital adrenal hyperplasia
(21-hydroxylase deficiency). Pediatr Res 13:1356-1360, 1979.
109. Rauh W, Levine LS, Gottesdiener K, Chow D, Oberfield SE, Gunczler P, Pareira P, New
MI: Adrenocortical function, electrolyte metabolism, and blood pressure during prolonged
adrenocorticotropin infusion in juvenile hypertension. J Clin Endocrinol Metab 49:52-7,
1979.
110. New MI, Lorenzen F, Pang S, Gunczler P, Dupont B, Levine LS: "Acquired" adrenal
hyperplasia with 21-hydroxylase deficiency is not the same genetic disorder as congenital
adrenal hyperplasia. J Clin Endocrinol Metab 48:356-359, 1979.
111. Loggie JMH, New MI, Robson AM: Hypertension in the pediatric patient: A reappraisal. J
Pediatr 94:685-699, 1979.
112. Loggie JMH, Londe S, New MI: Pediatric hypertension: Add HBP to your list of childhood
ills. Patient Care 12:16-24, 1978.
113. New MI, Gurpide E, Levine LS, Segal SJ, Soyka LF, VanWyk JJ, Yaffe SJ: Report of the
Conference on Estrogen Treatment of the Young. Pediatrics 62 part 2 (suppl):1087-1217,
1978.
114. Saenger P, Levine LS, Pang S, New MI: Sexual ambiguity at birth. In: SJ Kogan and ESE
Hafez (eds), Diagnosis in Andrology, Vol 4, Martinus Nijhoff Publishers, Boston, 1980, pp
31-52.
115. Yang SY, Levine LS, Zachmann M, New MI, Prader A, Oberfield SE, O'Neill GJ, Pollack
MS and Dupont B: Mapping of the 21-hydroxylase deficiency gene within the HLA linkage
group. Transplant Proc 10:753-755, 1978.
116. Brautbar C, Rosler A, Landau H, Cohen I, Nelken D, Cohen T, Levine C, Sack J, Benderli
A, Moses A, Lieberman E, Dupont B, Levine LS and New MI: No linkage between HLA
and congenital adrenal hyperplasia due to 11-ß-hydroxylase deficiency (Letter to the
Editor). N Engl J Med 300:205-206, 1979.
118. Oberfield SE, Case DB, Levine LS, Rapaport R, Rauh W, New MI: Use of the oral
angiotensin-I-convering enzyme inhibitor (Captopril) in childhood malignant hypertension.
J Pediatr 95:641-644, 1979.
119. Pang S, Shine S, Levine LS and New MI: Practical advances in cortisol and
dehydroepiandrosterone sulfate radiommunoassay using microfilter paper method. J Lab
Clin Med 95:515-524, 1980.
2/1/95
LIST OF PUBLICATIONS
10
MARIA I. NEW
120. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, Rosler A, Bradlow
HL, New MI: A syndrome of apparent mineralocorticoid excess associated with defects in
the peripheral metabolism of cortisol. J Clin Endocrinol Metab 49:757-764, 1979.
121. Saenger P, Schwartz E, Markenson AL, Graziano JH, Levine LS, New MI, Hilgartner MW:
Depressed serum somatomedin activity in ß-thalassemia. J Pediatr 96:214-218, 1980.
122. Pollack MS, Levine LS, Pang S, Owen RP, Nitowsky HM, Maurer D, New MI, Duchon M,
Merkatz IR, Sachs G, Dupont B: Prenatal diagnosis of congenital adrenal hyperplasia
21-hydroxylase.deficiency) by HLA typing. Lancet 1:1107-8, 1979.
123. Pollack MS, Maurer D, Levine LS, New MI, Pang S, Duchon MA, Owens RP, Merkatz IR,
Nitowsky HM, Sachs G, Dupont B: HLA typing of amniotic cells: The prenatal diagnosis of
congenital adrenal hyperplasia (21-OH-deficiency type). Transplant Proc XI:1726-1728,
1979.
124. Newman CB, Levine LS, New MI: Endocrine function in children with intrasellar and
suprasellar neoplasms before and after therapy. Am J Dis Child 135:259-262, 1981.
125. New MI, Levine LS: Endocrine diseases. In: E Wasserman and DS Gromish (eds), Survey
of Clinical Pediatrics, 7th edition, McGraw-Hill Book Company, New York, 1981, pp
427-454.
126. Oberfield SE, Levine LS, Wellner D, Novogroder M, Laino P,New MI: Ascorbic acid
treatment in nephropathic cystinosis in identical twins. Dev Pharmacol Therap 2:80-90,
1981.
127. Levine LS, New MI: Endocrine aspects of hypertension. In: CGD Brook (ed), Clinical
Paediatric Endocrinology, Blackwell Scientific Publications, Oxford, 1981, pp 479-491.
128. O'Neill GJ, Pollack MS, Yang SY, Levine LS, New MI, Dupont B: Gene frequencies and
genetic linkage disequilibrium for the HLA linked genes Bf, C2, C4S, C4F, 21-hydroxylase
deficiency and glyoxalase I. Trans Proc 11:1713-1718, 1979.
129. Lan NC, Matulich DT, Stockigt JR, Biglieri EG, New MI, Winter JS, McKenzie JK, Baxter
JD: Radioreceptor assay of plasma mineralocorticoid activity: role of aldosterone, cortisol
and deoxycorticosterone in various mineralocorticoid-excess states. Circ Res 46(suppl
I):94-100, 1980.
130. Mininberg DT, Levine LS, New MI: Current concepts in congenital adrenal hyperplasia.
Invest Urol 17:169-175, 1979.
2/1/95
LIST OF PUBLICATIONS
11
MARIA I. NEW
131. Lorenzen F, Pang S, New MI, Pollack MS, Oberfield SE, Dupont B, Chow D, Schneider B,
Levine LS: Studies of the C-21 and C-19 steroids and HLA genotyping in siblings and
parents of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
J Clin Endocrinol Metab 50:572-577, 1980.
132. Levine LS, Rauh W, Gottesdiener K, Chow D, Gunczler P, Rapaport R, Pang S, Schneider
B, New MI: New studies of the 11ß-hydroxylase and 18-hydroxylase enzymes in the
hypertensive form of congenital adrenal hyperplasia. J Clin Endocrinol Metab 50:258-263,
1980.
133. Pang S, Levine LS, Cederqvist LL, Fuentes M, Riccardi VM, Holcombe JH, Nitowsky HM,
Sachs G, Anderson CE, Duchon MA, Owens R, Merkatz 1, New MI: Amniotic fluid
concentrations of 05 and 04 steroids in fetuses with congenital adrenal hyperplasia due to
21-hydroxylase deficiency and in anencephalic fetuses, J Clin Endocrinol Metab
51:223-229,1980.
134. Pang S, Levine LS, Lorenzen F, Chow D, Pollack MS, Dupont B, Genel M, New MI:
Hormonal studies in obligate heterozygotes and siblings of patients with 11ß-hydroxylase
deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 50:586-589, 1980.
135. Laron Z, Pollack MS, Zamir R, Roitman A, Dickerman Z, Levine LS, Lorenzen F, O'Neill
GJ, Pang S, New MI, Dupont B: Late onset 21-hydroxylase deficiency and HLA in the
Ashkenazi population: A new allele at the 21-hydroxylase locus. Human Immunol 1:55-66,
1980.
136. Pollack MS, Levine LS, Zachmann M, Prader A, New MI, Oberfield SE, Dupont B:
Possible genetic linkage disequilibrium between HLA and the 21-hydroxylase deficiency
gene (congenital adrenal hyperplasia). Trans Proc XI:1315-1316, 1979.
137. Levine LS, New MI, Pollack MS, Dupont B: Prenatal diagnosis of congenital adrenal
hyperplasia (Letter to the Editor). Lancet 2:637, 1979.
138. New MI, Oberfield SE, Levine LS, Dupont B, Pollack MS, Gill Jr JR, Bartter FC: Autosomal
dominant transmission and absence of HLA linkage in dexamethasone-suppressible
hyperaldosteronism (Letter to theEditor). Lancet 1:550-551, 1980.
139. Levine LS, Pang S, Dupont S, Pollack MS, Lorenzen L, New MI: Detection of heterozygote
of 21-hydroxylase deficiency (Letter to the Editor), Lancet 1:603-604, 1980.
140. Sonino N, Levine LS, Vecsei P, New MI: Parallelism of 11B- and 18-hydroxylation
demonstrated by urinary free hormones in man. J Clin Endocrinol Metab 51:557-560,
1980.
141. Sonino N, Chow D, Levine LS, New MI: Clinical response to metyrapone as indicated by
measurement of mineralocorticoids and glucocorticoids in normal children. Clin Endocrinol
(Oxf) 14:31-39, 1981.
2/1/95
LIST OF PUBLICATIONS
12
MARIA I. NEW
142. New MI, Levine LS: Low-renin hypertension with hyperaldosteronism in childhood, Prog
Biochem Pharmacol 17:54-57, 1980.
143. New MI, Dupont B, Levine LS: HLA and adrenal disease. In: NR Farid (ed), HLA in
Endocrine and Metabolic Disorders, Academic Press, New York, 1981, pp 177-208.
144. Saenger P, Levine LS, New MI: Male pseudohermaphroditism due to abnormal
testosterone biosynthesis and metabolism, In: SJ Kogan and ESE Hafez (eds), Clinics in
Andrology, Vol 7. In: Pediatric Andrology, Martinus Nijhoff Publishers, Boston, 1981, pp
87-97.
145. New MI, Levine LS: Inborn errors of steroid biosynthesis. In: HLJ Makin (ed),
Biochemistry of Steroid Hormones, Second Edition, Blackwell Scientific Publishers, Oxford,
1984, pp 595-632.
146. New MI, Levine LS: Congenital adrenal hyperplasia. In: AJ Moss (ed), Pediatrics Update:
Reviews for Physicians, 1981 Edition, Elsevier North Holland, New York, 1981, pp
223-235.
147. New MI, Levine LS: Adrenal hyperplasia in intersex states. In: N Josso (ed), Intersex
Child, In: Z Laron (ed), Pediatric and Adolescent Endocrinology, S Karger, Basel, 1981,
8:51-64.
148. New MI, Levine LS: Female pseudohermaphroditism. In: JJ Sciarra, L Speroff, and JL
Simpson (eds), Gynecology and Obstetrics, vol 5, Harper and Row, Hagerstown, 1981, pp
1-7.
149. Sonino N, Levine LS, New MI: Mineralocorticoid and metabolic response to metyrapone in
normotensive children and children with dexamethasone-suppressible and primary
hyperaldosteronism. Acta Endocrinol 98:87-94, 1981.
150. New MI, Levine LS: Hypertension of childhood with suppressed renin, Endocrine Reviews
1:421-430, 1980.
151. New MI, Levine LS (guest editors): Endocrine disorders in children. Pediatr Ann
9:131-173, 1980.
152. New MI, Levine LS (guest editors): Hormonal conditions. Pediatr Ann 9:359-405, 1980.
153. Oberfield SE, Levine LS, Rauh W, Pang S, Gottesdiener K, New MI: Androgens in
childhood hypertension. In: E Cacciari and A Prader (eds), Pathophysiology of Puberty:
Proceedings of the Serono Symposia, Vol 36, Academic Press, London, 1980, pp
157-162.
2/1/95
LIST OF PUBLICATIONS
13
MARIA 1. NEW
154. Rauh W, Levine LS, New MI: The role of dietary salt in juvenile hypertension, In: G
Giovannelli, MI New and S Gorini (eds), Hypertension in Children and Adolescents,
Raven Press, New York, 1981, pp 35-44.
155. New MI: Investigation of new forms of hypertension in childhood. In: G Giovannelli, MI
New and S Gorini (eds), Hypertension in Children and Adolescents, Raven Press, New
York, 1981, pp 157-160.
156. New MI, Levine LS: Hypertension in childhood and adolescence. Cardiovas Rev Rep,
3:115-122, 1982.
157. Levine LS, Dupont B, Lorenzen B, Pang S, Pollack MS, Oberfield SE, Kohn B, Lemer A,
Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L,
Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F, New MI:
Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal
hyperplasia. J Clin Endocrinol Metab 51:1316-1324, 1980.
158. Dupont B, Pollack MS, Levine LS, O'Neill GJ, Hawkins BR, New MI: Congenital adrenal
hyperplasia: Joint report from the 8th International Histocompatibility Workshop. In: PI
Terasaki (ed), Histocompatibility Testing 1980, UCLA Tissue Typing Laboratory, Los
Angeles, 1980, pp 693-706.
159. Curtis JA, Monaghan HP, New MI, Bailey JD: Selective hypoaldosteronism in infancy. Am
J Dis Child 137:633-636, 1983.
160. Rifkind AB, Saenger P, Levine LS, Pareira J, New MI: Effects of growth hormone on
antipyrine kinetics in children. Clin Pharmacol Therap 30:127-132, 1981.
161. New MI, Levine LS: The infant with ambiguous genitalia. In: Syllabus 32nd Ann
Postgraduate Assembly of the Endocrine Society, 1980, pp 470.
162. Kuhnle U, Chow D, Rapaport R, Pang S, Levine LS, New MI: The 21-hydroxylase activity
in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hypérplasia.
J Clin Endocrinol Metab 52:534-544, 1981.
163. Mininberg DT, Levine LS, New MI: Current concepts in congenital adrenal hyperplasia. In:
Advances in the Study of Birth Defects, Chap 11, In: TVN Persaud (ed), Genetic
Disorders, Syndromology and Prenatal Diagnosis, Vol 5,MTP Press, Ltd, Lancaster, 1982,
pp 181-196.
165. Teitelman G, Joh TH, Park D, Brodsky M, New MI, Reis DJ: Expression of the adrenergic
phenotype in cultured fetal adrenal medullary cells: role of intrinsic and extrinsic factors.
Develop Biology 89:450-459, 1982.
166. New MI, Dupont B, Pang S, Pollack MS, Levine LS: An update of congenital adrenal
hyperplasia. Rec Prog Horm Res 37:105-181, 1981.
2/1/95
LIST OF PUBLICATIONS
14
MARIA I. NEW
167. New MI, Levine LS, Pang S: Adrenal androgens and growth. In: M Ritzen, A Aperia, K
Hall, A Larsson, A Zetterberg, and R Zetterstrom (eds), The Biology of Normal Human
Growth, Raven Press, New York, 1981, pp 285-295.
168. Lee SM, Lightner E, Witte M, Oberfield SE, Levine LS, New MI: Dexamethasone
suppressible hyperaldosteronism in.a child with néphrosclerosis, Acta Endocrinol
99:251-255, 1982.
170. Levine LS, Dupont B, Lorenzen F, Pang S, Pollack MS, Oberfield SE, Kohn B, Lemer A,
Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L,
Giovannelli G, Virdis R,* Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F, New MI:
Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin
Endocrinol Metab 53:1193-1198, 1981.
171. New MI, Lorenzen F, Lemer AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E,
Levy DJ, Pang S, Levine LS: Genotyping steroid 21-hydroxylase deficiency: hormonal
reference data. J Clin Endocrinol Metab 57:320-326, 1983.
172. New MI, Grumbach K, Levine LS: Congenital adrenal hyperplasia, In: AEH Emery and DL
Rimoin (eds), Principles and Practice of Medical Genetics, Churchill Livingstone, Inc, New
York, 1983, pp 1202-1226.
173. Lan NC, Matulich DT, Stockigt JR, Biglieri EG, New MI, Baxter JD: Role of steroids in
various states of mineralocorticoid-excess hypertension: Analysis by mineralocorticoid
receptor assay. In: G Giovannelli, MI New, and S Gorini (eds), Hypertension in Children
and Adolescents, Raven Press, New York, 1981, pp 165-175.
174. Pollack MS, Levine LS, O'Neill GJ, Pang S, Lorenzen F, Kohn B, Rondanini GF, Chiumello
G, New MI, Dupont B: HLA linkage and B14,D BfS haplotype association with the
genes for late onset and cryptic 21-hydroxylase deficiency. Am J Hum Genet 33:540-550,
1981.
175. Rapaport R, Levine LS, Petrovic M, Wilson T, Draznin M, Bejar RL, Johanson A, New MI:
The renin-aldosterone system in cystic fibrosis, J Pediatrics 98:768-771, 1981.
176. New MI, Dupont B, Pollack MS, Levine LS: The biochemical basis for genotyping
21-hydroxylase deficiency. Human Genetics 58:123-127, 1981.
177. Pollack MS, New MI, O'Neill GJ, Levine LS, Callaway C, Pang S, Cacciari E, Mantero F,
Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R,
Bartolotta E, Migliori C, Pintor C, Tato L, Barboni E, Dupont B: HLA genotypes and
HLA-linked genetic markers in Italian patients with classical 21-hydroxylase deficiency.
Human Genetics 58:331-337, 1981.
2/1/95
LIST OF PUBLICATIONS
15
MARIA I. NEW
178. New MI: The role of steroid hormones in the development of low-renin hypertension of
childhood. In: JMH Loggie, MJ Horan, AB Gruskin, AR Hohn, JB Dunbar and RJ Havlik
(eds), NHLBI Workshop on Juvenile Hypertension: Proceedings from a Symposium,
Bethesda, Maryland, May 26 - 27, 1983, Biomedical Information Corp, New York, 1984, pp
283-304.
179. Oberfield SE, Levine LS, Stoner E, Chow D, Rauh W, Greig F, Lee SM, Lightner E, Witte
M, New MI: Adrenal glomerulosa function in patients with dexamethasone-suppressible
hyperaldosteronism. J Clin Endocrinol Metab 53:158-164, 1981.
180. Kuhnle U, Rosler A, Pareira JA, Gunzcler P, Levine LS, New MI: The effects of long-term
normalization of sodium balance on linear growth in disorders with aldosterone deficiency.
Acta Endocrinol 102:577-582, 1983.
181. New MI: Precocious puberty, In: DT Krieger and CW Bardin (eds), Current Therapy in
Endocrinology 1983-1984, BC Decker, Philadelphia, 1983, pp 7-11.
182. Wachtel SS, New MI: Studies on H-Y antigen: The genetic basis of abnormal gonadal
differentiation. In: Clinics in Andrology, Vol 7. In: SJ Kogan and ESE Hafez (eds),
Pediatric Andrology, Martinus Nijhoff Publishers, Boston, 1981, pp 59-69.
183.
Pang S, Murphey M, Levine LS, Spence DA, Leon A, LaFranchi S, Surve AS, New MI: A
pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol
Metab 55:413-420, 1982.
184. New MI, Levine LS (guest editors): Endocrine disorders. Ped Annals 10:323-375, 1981.
185. New MI, Levine LS: New developments in congenital adrenal hyperplasia. Ped Annals
10:346-355, 1981.
186. New MI, Levine LS: Hypertension and the adrenal cortex. In: SA Kaplan (ed), Clinical
Pediatric and Adolescent Endocrinology, WB Saunders Co, Philadelphia, 1982,
187-198.
187. Levy DJ, Levine LS, New MI: Male pseudohermaphroditism. Ped Review 3:273-283,
1982.
188. New MI, Dupont B, Grumbach K, Levine LS: Congenital adrenal hyperplasia and related
conditions. In: JB Stanbury, JB Wyngaarden, DS Fredrickson, JL Goldstein, and MS
Brown (eds), The Metabolic Basis of Inherited Disease, 5th edition, McGraw-Hill Book
Company, New York, 1982, pp 973-1000.
189.
New MI, Levine LS: Congenital adrenal hyperplasia. Clin Biochem 14:258-272, 1981.
2/1/95
LIST OF PUBLICATIONS
16
MARIA 1. NEW
190. Saenger P, Levine LS, Irvine WJ, Gottesdiener K, Rauh W, Sonino N, Chow D, New MI:
Progressive adrenal failure in polyglandular auto immune disease. J Clin Endocrinol
Metab 54:863-868, 1982.
191. Mininberg DT, Levine LS, New MI: Congenital adrenal hyperplasia. Pathology Annual
17:179-195, 1982.
193. New MI, Dupont B, Pang S, Pollack MS, Levine LS: Metabolic errors of adrenal
steroidogenesis, In: Fetal Endocrinology and Metabolism. In L Martini. and VHT James
(eds), Current Topics in Experimental Endocrinology, Vol 5, Academic Press, New York,
1983, pp 309-358.
195. New MI, Stoner E, Pang S, Levine LS: Genetic steroidogenic defects causing abnormal
pubertal changes. In: S Venturoli, C Flamigni, JR Givens (eds), Adolescence in Females,
Proceedings of the Eighth Annual Symposium on Gynecologic Endocrinology, October
24-26, 1983, University of Bologna, Bologna, Italy, Year Book Medical Publishers,
Chicago, 1985, pp 341-372.
196. Oberfield SE, Allen JC, Pollack J, New MI, Levine LS: Long term endocrine sequelae
following treatment of medulloblastoma: a prospective study of growth and thyroid function.
J Pediatrics, 108:219-223, 1986.
197. Levine LS, New MI: Neoplasms associated with congenital adrenal hyperplasia (Letter to
the Editor). J Pediatrics 100:506-507, 1982.
198. New MI, Oberfield SE, Carey RM, Greig F, Ulick S, Levine LS: A genetic defect in cortisol
metabolism as the basis for the syndrome of apparent mineralocorticoid excess. In: F
Mantero, EG Biglieri and CRW Edwards (eds), Endocrinology of Hypertension, Serono
Symposia No 50, Academic Press, New York, 1982, pp 85-101.
199. New MI, Dupont B, Lorenzen F, Pang S, Pollack MS, Oberfield SE, Kohn B, Lerner A,
Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L,
Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F, Levine LS:
Recognition of allelic variants of 21-hydroxylase deficiency by HLA genotyping, hormonal
and clinical evaluation, In: G Chiumello and M Sperling (eds), Recent Progress in Pediatric
Endocrinology, Serono Series, Raven Press, New York, 1983, pp 183-219.
200. Oberfield SE, Levine LS, Carey RM, Greig F, Ulick S, New MI: Metabolic and blood
pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid
excess. J Clin Endocrinol Metab 56:332-339, 1983.
201. Oberfield SE, Levine LS, New MI: Adrenal disorders: causes and therapy for children and
adolescents. Consultant 22:328-343, 1982.
2/1/95
LIST OF PUBLICATIONS
17
MARIA I. NEW
202. Meyer-Bahlburg HFL, Ehrhardt AA, Bell JJ, Cohen SF, Healey JM, Feldman JF, Morishima
A, Baker SW, New MI: Idiopathic precocious puberty in girls: psychosexual development.
J Youth Adol 14:339-353, 1985.
203. O'Neill GJ, Dupont B, Pollack MS, Levine LS, New MI: Complement C4 allotypes in
congenital adrenal hyperplasia due to 21-hydroxylase deficiency: further evidence for.
different allelic variants at the 21-hydroxylase locus. Clin Immunol Immunopathol
23:312-322, 1982.
204. New MI, Oberfield SE, Levine LS: Hypertension in children. In: J Genest, O Kuchel, P
Hamet, M Cantin (eds), Hypertension: Pathophysiology and Treatment (2nd edition),
McGraw-Hill Book Co, New York, 1983 pp 853-889.
205. New MI, Levine LS: Steroid 21-hydroxylase deficiency. In: MI New and LS Levine (eds),
Adrenal Diseases in Childhood, In: Z Laron (ed), Pediatric and Adolescent Endocrinology,
Vol 13, S Karger AG, Basel, pp 1984,1-46.
206. Oberfield SE, Rapaport R, Levine LS, New MI: Long-term treatment of childhood
hypertension with captopril. Ped Annals 11:614-621, 1982.
207. Oberfield SE, Levine LS, New MI: Childhood hypertension due to adrenocortical disorders.
Ped Annals 11:623-628, 1982.
208. Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, Levy D, Lerner A, Rondanini GF,
Dupont B, New MI: Late-onset steroid 21-hydroxylase deficiency: A variant of classical
congenital adrenal hyperplasia. J Clin Endocrinol Metab 55:817-827, 1982.
209.
New MI: Erkrankungen der nebennierenrinde: 11B- und 21-hydroxylase mangel
[Adrenocortical Dysfunction: 21- and 11ß-hydroxylase deficiencies]. In: D Gupta (ed),
Endokrinologie der Kindheit und Adoleszenz, Georg, Thieme, Verlag, New York, 1986, pp
182-228.
210. New MI, Levine LS, Oberfield SE: Low renin hypertension in childhood, In: F Lifshitz (ed),
Pediatric Endocrinology, A Clinical Guide, Marcel Dekker, New York, 1985, pp 591-614.
211. New MI, Pang S, Levine LS: An update of congenital adrenal hyperplasia. In: F Lifshitz
(ed), Pediatric Endocrinology, A Clinical Guide, Marcel Dekker, New York, 1985, pp
203-235.
212. Oberfield SE, Levine LS, Firpo A, Lawrence D, Stoner E, Levy DJ, Sen S, New MI:
Primary hyperaldosteronism in childhood due to unilateral macronodular hyperplasia.
Hypertension, 6:75-84, 1984.
213.
Loche S, Porcelli F, Rosen M, Feffer M, Stoner E, New MI, Clinical applications of the
rapid high pressure liquid chromatographic determination of serum córtisol. In:
Proceedings of the Eighth International Symposium on Column Liquid Chromatography, J
Chromatography, 317:377-382, 1984.
2/1/95
LIST OF PUBLICATIONS
18
MARIA 1. NEW
214. New MI: Hiperplasia adrenal congenita por deficit de 21-hidroxilasa (forma clasica y
variantes). In: I Rodriquez Rodriguez, A Jimenez Cruz (eds), VI Reunion Nacional de
Endocrinologia Pediatrica, November 2-3, 1984, Puerto de la Cruz, Tenerife, 1984, pp
75-122.
215. Mandel FP, Chang RJ, Dupont B, Pollack MS, Levine LS, New MI, Lu JK, Judd HL: HLA
genotyping in family members and patients with familial polycystic ovarian disease. J Clin
Endocrinol Metab 56:862-864, 1983.
216. Pang S, Levine LS, Stoner E, Opitz JM, Pollack MS, Dupont B, New MI: Nonsalt-losing
congenital adrenal hyperplasia due to 3ß-hydroxysteroid dehydrogenase deficiency with
normal glomerulosa function. J Clin Endocrinol Metab 56:808-818, 1983.
217. Virdis R, Levine LS, Levy D, Pang S, Rapaport R, New MI: Congenital adrenal hypoplasia:
two new cases. J Endocrinol Invest, 6:51-54, 1983.
218. Pang S, Murphey W, Levine LS, Spence DA, Leon A, LaFranchi S, Surve AS, New MI:
Newborn screening for congenital adrenal hyperplasia in Alaska. In: H Naruse, M Irie
(eds), Neonatal Screening, Excerpta Medica International Congress Series 606, 1983, pp
316-323.
219. McVie R, Levine LS, New MI: Aldosterone concentration in saliva. In: GF Read, D
Riad-Fahmy, RF Walker, K Griffiths (eds), Immunoassay of Steroids in Saliva,
Proceedings of the Ninth Tenovus Workshop, Cardiff November 1982, Alpha Omega
Publishing, Wales, 1984, pp 295-299.
220. Kelch RP, Virdis R, Rapaport R, Greig F, Levine LS, New MI: Congenital Adrenal
Hypoplasia. In: MI New and LS Levine (eds), Adrenal Diseases in Childhood, In: Z Laron
(ed), Pediatric and Adolescent Endocrinology, Vol 13, S Karger AG, Basel, 1984, pp
156-161.
221. New MI, Dupont B, Pang S, Pollack MS, Levine LS: Enzymatic defects of adrenal
steroidogenesis. In: K Fotherby. and SB Pal (eds), Steroid Converting Enzymes and
Diseases, Walter de Gruyter and Co, Berlin/New York, 1984, pp 1-71.
222. New MI, Levine LS, Temeck JW: Disorders of the adrenal gland, In: SS Gellis and BM
Kagan (eds), Current Pediatric Therapy, 11th edition, WB Saunders Co, Philadelphia,
1984, pp 295-299.
223. Stoner E, Starkman H, Wellner D, Wellner VP, Sassa S, Rifkind AB, Grenier A, Steinherz
PG, Meister A, New MI, Levine LS: Biochemical studies of a patient with hereditary
hepatorenal tyrosinemia: evidence of glutathione deficiency. Pediatr Res 18:1332-1336,
1984.
224. Stiehm ER, DeVivo DC, Brann Jr AW, Fisher DA, Hodson WA, New MI, Shearer WT,
Sokol RJ, Sunshine P and Taeusch Jr HW: Advances in perinatology from the clinical
research centers. Pediatr Res, 18:197-212, 1984.
2/1/95
LIST OF PUBLICATIONS
19
MARIA I. NEW
225. New MI, Levine LS, Pang S, Pollack MS, Dupont B: Adrenal components in abnormal
sexual differentiation. In: M Serio, M Motta, M Zanisi, L Martini (eds), Sexual
Differentiation: Basic and Clinical Aspects, Raven Press, New York, pp 321-349, 1984.
226. Greig F, Oberfield SE, Levine LS, Ghavimi F, Pang S, New MI: Recovery of adrenal
function after treatment of adrenocortical carcinoma with o,p'-DDD, Clin Endocrinol
20:389-399, 1984.
227. Pang S, New MI: Past, present, and future needs of neonatal screening in congenital
disorders and in inbom errors of metabolism. In: RA Wapnir (ed), Congenital Metabolic
Diseases: Diagnosis and Treatment, Marcel Dekker, New York, 1985, pp 85-102.
228. Sen S, Bumpus FM, Oberfield SE, New MI: Development and preliminary application of a
new assay for aldosterone stimulating factor (ASF). Hypertension 5 (supp I): I-27-I-31,
1983.
229. Ehrhardt AA, Meyer-Bahlburg HFL, Bell JJ, Cohen SF, Healey JM, Stiel R, Feldman JF,
Morishima A, New MI: Idiopathic precocious puberty in girls: psychiatric follow-up in
adolescence. J Am Acad Child Psychiatry 23, 1:23-33, 1984.
230. New MI: Hipertension endocrina en la infancia. In: I Rodriquez Rodriguez, A Jimenez Cruz
(eds), VI Reunion Nacional de Endocrinologia Pediatrica, November 2-3, 1984, Puerto de
la Cruz, Tenerife, 1984, pp 123-188.
231. New MI, Levine LS: Recent advances in 21-hydroxylase deficiency. Ann Rev Med,
35:649-663, 1984.
232. New MI: Salt-wasting congenital adrenal hyperplasia. Pediatr Emergency Casebook,
2:1-15, 1983.
233. Levine LS, New MI: Congenital adrenal hyperplasia. In: N Lavin (ed), Manual of
Endocrinology and Metabolism, Little Brown and Co, Boston, 1986, pp 143-161.
234. Levine LS, Oberfield SE, New MI: Hypertension in childhood. In: N Lavin (ed), Manual of
Endocrinology and Metabolism, Little Brown and Co, Boston, 1986, pp 163-176.
235. White PC, New MI, Dupont B: Cloning and expression of cDNA encoding a bovine adrenal
cytochrome P-450 specific for steroid21-hydroxylation. Proc Natl Acad Sci USA,
81:1986-1990, 1984.
236. New MI: Congenital enzymatic defects of the adrenal. In: DC Anderson and JSD Winter
(eds), Butterworth's International Medical Reviews - Endocrinology; The Adrenal Cortex,
Butterworth, London, 1985, pp 120-153.
2/1/95
LIST OF PUBLICATIONS
20
MARIA I. NEW
237. Rosenfeld RG, Hintz RL, Johanson AJ, Brasel JA, Burstein S, Chemausek SD, Clabots T,
Frane J, Gotlin RW, Kuntze J, Lippe BM, Mahoney PC, Moore WV, New MI, Saenger P,
Stoner E, Sybert V: Methionyl human growth hormone and oxandrolone in Turner
syndrome: Preliminary results of a prospective randomized trial. J Pediatr 6:936-940, 1986.
238. New MI, Oberfield SE, Schneider B, Temeck J, Pang S: Polymorphism of ACTH in
hyperaldosteronism and adrenal hyperplasia. In: D Gupta (ed), Paediatric
Neuroendocrinology, Croom Helm Ltd, Kent, 1985, pp 173-189.
239. New MI, Temeck J, Grimm R, Pang S: An overview of disorders of sexual differentiation.
Resident and Staff Physician, 31:21-43, 1985.
240. New MI: The HLA system in congenital adrenal hyperplasia. In: CGD Brook and DM
Styne (eds), Current Concepts in Pediatric Endocrinology, chap 2, Prager, 1987, pp 28-61.
241. New MI: Female pseudohermaphroditism n-21-hydroxylase deficiency. In: JB Josimovich,
JJ Gold, (eds), Gynecologic Endocrinology, 4th Edition, Plenum Press, New York, 1987,
pp 327-347.
242. Stoner E, Loche S, Mirth A, New MI: Clinical utility of adrenal steroid measurement by high
pressure liquid chromatography (HPLC) inpediatric endocrinology. J Chromatography,
374: 358-362, 1986.
243. Fallo F, Oberfield SE, Levine LS, Stoner S, Greig F, New MI, Sniderman K, Saddekni S,
Sos TA: Evaluation of percutaneous transluminal renal angioplasty in childhood
hypertension. Int J Ped Neph 6:261-226, 1985.
244. New BL, New MI: External genital ambiguity, In: M Farber (ed), Human Sexuality: The
Psychosexual Effects of Disease, Macmillan Publishing Company, Inc, New York, 1985, pp
87-95.
245. New MI: Low-renin hypertension in childhood. In: F Mantero, EG Biglieri, JW Funder, BA
Scoggins (eds), The Adrenal Gland and Hypertension, Serono Symposia, vol 27, Raven
Press, New York, 1985, pp 319-336.
246. White PC, New MI, Dupont B: HLA-linked congenital adrenal hyperplasia results from a
defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc
Natl Acad Sci USA 81:7505-7509, 1984.
247. Pang S, Lemer AJ, Stoner E, Levine LS, Oberfield SE, Engel I, New MI: Late-onset
adrenal steroid 3ß-hydroxysteroid dehydrogenase deficiency I: A cause of hirsutism in
pubertal and postpubertal women. J Clin Endocrinol Metab, 60:428-439, 1985.
248. Speiser PW, Stoner E, New M: Pseudohypoaldosteronismi a review and report of two new
cases. In: GP Chrousos, DL Loriaux, and MB Lipsett, (eds), Steroid Hormone Resistance,
Plenum Publishing Company, New York, 1986, pp 173-195.
2/1/95
LIST OF PUBLICATIONS
21
MARIA I. NEW
249. New MI: An update of congenital adrenal hyperplasia. In: Syllabus of the 36th Annual
Postgraduate Assembly of the Endocrine Society, Dallas, Oct 15-16, 1984, pp 187-217.
250. White PC, New MI, Dupont B: Cloning and expression of cDNA encoding a bovine adrenal
cytochrome P-450 specific for steroid 21-hydroxylation. In: The Role of Genetic
Predisposition in Responses to Chemical Exposures, Banbury Report No 17, Cold Spring
Harbor, NY, 1984.
251. White PC, Dupont B, New MI: Molecular cloning of steroid 21-hydroxylase. Endocrine
Research 10:335-346, 1985.
252. White PC, New MI, Dupont B: Molecular cloning of steroid 21-hydroxylase. Ann NY Acad
Sci 458:277-288, 1985.
253. White PC, Chaplan DD, Weis JH, Dupont B, New MI, Seidman JG: Two steroid
21-hydroxylase genes are located in murine S regions. Nature 312:465-467, 1985.
254. Pang S, Spence DA, New MI: Newborn screening for congenital adrenal hyperplasia with
special reference to screening in Alaska. Ann NY Acad Sci, 458:90-102, 1985:
255. Pang S, Pollack MS, Loo M, Green O, Nussbaum R, Clayton G, Dupont B, New MI:
Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia. J
Clin Endocrinol Metab 61:89-97, 1985.
256. Pang S, Pollack MS, Loo M, Green O, Nussbaum R, Clayton G, Dupont B, New M: Pitfalls
of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia. Ann NY
Acad Sci 458:111-129, 1985.
257. Stoner E, DiMartino J, Kuhnle U, Levine LS, Oberfield SE, New MI: Is salt-wasting in
congenital adrenal hyperplasia due to the same gene as the fasciculata defect? Clin
Endocrinol 24: 9-20, 1986.
258. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI: High frequency of
nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet, 37:650-667, 1985.
259. New MI: Diagnosis and management of ambiguous genitalia in the newborn. In: IH Porter,
N-Hatcher, A Willey (eds), Perinatal Genetics, New York, Academic Press, 1986, pp
133-157.
260. Speiser PW, Martin KO, Kao-Lo G, New MI: Excess mineralocorticoid receptor activity in
patients with dexamethasone-suppressible hyperaldosteronism is under
adrenocorticotropin control. J Clin Endocrinol Metab 61:297-302, 1985.
261. White PC, Grossberger D, Onufer BJ, New MI, Dupont B, Strominger JL: Two genes
encoding steroid 21-hydroxylase are located near the genes encoding the fourth
component of complement in man. Proc Natl Acad Sci USA 82:1089-1093, 1985.
2/1/95
LIST OF PUBLICATIONS
22
MARIA I. NEW
262. Speiser PW, New MI: Genetics of steroid 21-hydroxylase deficiency. Trends in Genetics
1:275-278, 1985.
263. New MI: Clinical and endocrinological aspects of 21-hydroxylase deficiency Ann NY Acad
Sci 458:1-27, 1985.
264. New MI: Genetics of congenital adrenal hyperplasia. In: CJ Papadatos, CB Bartsocas
(eds), Endocrine Genetics and Genetics of Growth, Alan R Liss, Inc, New York, 1985, pp
233-241.
265. DiMartino-Nardi J, Stoner E, O'Connell A, New MI: The effect of treatment on final height
in congenital adrenal hyperplasia. Acta Endocrinol (Suppl. Prader Liber Amicorum)
279:305-314, 1986.
266. Van Thiel DH, Gartner LM, Thorp FK, Newman SL, Lindahl JA, Stoner E, New MI, Starzl
TE: Resolution of the clinical features of tyrosinemia following orthotopic liver
transplantation for hepatoma. J Hepatol 3:42-48, 1986.
267. Fallo F, Oberfield SE, Levine LS, Stoner E, Greig F, Sniderman K, Saddekni S, Sos T,
New MI: Percutaneous transluminal renal angioplasty in childhood hypertension. In: IH
Slater (ed), Clinical and Experimental Hypertension. In: K Scharer, W Rascher, D Ganten,
U Laaser, (eds), Proceedings of the Second International Symposium on Hypertension in
Children and Adolescents, Oct 11-12, 1985, Heidelberg, FRG, Vol A8, No 4,5 Marcel
Dekker, New York, 1986, pp 887-892.
268. New MI: Premature thelarche and estrogen intoxication. In: JA McLachlan (ed), Estrogens
in The Environment II, Elsevier Science Publishing Co,Inc, New York, 1986, pp 349-357.
269. White PC, New MI, DuPont B: Adrenal 21-hydroxylase cytochrome P-450genes within the
MHC class III region. Immuno Reviews 87: 123-150, 1985.
270. New MI, Levine LS, Temeck JW: Disorders of the adrenal gland. In: SS Gellis and BM
Kagan (eds), Current Pediatric Therapy, 12th edition, WB Saunders Co, Philadelphia,
1986, pp 308-312.
271. Nass R, Petito C, Stoner E, New MI: Neuronal ceroid lipofuscinosis with
hypergonadotropic hypogonadism. J Child Neurology 1:142-144, 1986.
272. Ghizzoni L, Muller-Eberhard U, New MI, Finlayson M, Johnson EF: Characterization by
serial biopsy of variations among untreated rabbits in hepatic progesterone 21-hydroxylase
activity. Biochem Biophysical Comm 130:43-49, 1985.
273. New MI, Speiser PW: Genetics of adrenal steroid 21-hydroxylase deficiency. Endocrine
Rev 7:331-349, 1986.
274. National Institutes of Health Consensus Development Conference Statement, (MI New,
Panel Member; J Hirsch, Chairman), Health Implications of Obesity. Annals Int Med 103:
147-151, 197-1077, 1985.
2/1/95
LIST OF PUBLICATIONS
23
MARIA I. NEW
275. Temeck J, Pang S, Nelson C and New MI: Genetic defect of steroidogenesis in premature
pubarche. J Clin Endocrinol Metab 64:609-617, 1987.
276. New MI: Adrenal: Review of anatomy, biochemistry and physiology; CAH: Genetics,
clinical variants, diagnosis and management. Syllabus, Current Review of Pediatric
Endocrinology, Serono Symposia, WashDC, May 1-4,1986.
277. Loche S, Rifkind AB, Stoner E, Faedda A, Garabedian MC, New MI: Microfilter paper
method for antipyrine determination in whole blood by high pressure liquid
chromatography. Thera Drug Monit 8:214-218, 1986.
278. New MI: Update on congenital adrenal hyperplasia. In: 37th Ann Postgraduate Assembly -
Endocrine Soc Syllabus, Miami, Oct 14-18, 1985.
279. Stoner E, New MI: Hypertensive disorders of childhood. In: DT Minenberg, (guest editor),
Hypertension in Childhood. In: RM Ehrlich, (ed), Dialogues in Pediatric Urology, Wm J
Miller Associates, Pearl River NY, 1985, pp.2-4.
280. DiMartino-Nardi J, New MI: Low-renin hypertension. Pediatr Nephrol 1:99-108, 1987.
281. New MI: Hypertension, its treatment, and involvement of endocrine glands. In: L Cavallo,
G Chiumello, DB Grant, MI New, F Schettini (eds), International Symposium, Endocrine
Involvement in Chronic Diseases in Children, Arti Grafiche Defa, Milano, 1986, pp
119-125.
282. Dupont B, Virdis R, Lerner AJ, Pollack MS, New MI: Distinct HLA-B antigen associations
for the salt-wasting and simple virilizing forms of congenital adrenal hyperplasia due to
21-hydroxylase deficiency. In: ED Albert, MP Baur, WR Mayr (eds), Histocompatibility
Testing 1984, Springer-Verlag, Berlin, 1984, p 660.
283. New MI, Stoner E, DiMartino-Nardi J: Apparent mineralocorticoid excess causing
hypertension and hypokalemia in children. In: IH Slater (ed), Clinical and Experimental
Hypertension. In: K Scharer, W Rascher, D Gantern, U Laaser (eds), Proceedings of the
Second International Symposium on Hypertension in Children and Adolescents, Oct 11-12,
1985, Heidelberg, FRG, Vol A8, No 4,5, Marcel Dekker, NY, 1986, pp 751-772.
284. Loche S, Rifkind AB, Conney AH, Stoner E, New MI: Antipyrine clearance in congenital
adrenal hyperplasia. Clin Endocrinol 25:233-239, 1986.
285. Dupont B, Pollack MS, New MI: Disease susceptibility genes in the HLA complex.
Banbury Report 16: 1984, pp 297-307.
286. Speiser PW, Martin KO, DiMartino-Nardi J, Stoner E, New MI: Excess mineralocorticoid
receptor activity in patients with dexamethasone-suppressible hyperaldosteronism is under
adrenocorticotropin control. In: MI New and P Borelli (eds), Dexaméthasone-Suppressible
Hyperaldosteronism, Serono Symposia Review No 10, Ares-Serono Symposia, Rome,
Italy, 1986, pp 60-68.
2/1/95
LIST OF PUBLICATIONS
24
MARIA I. NEW
287. White PC, New MI, Dupont B: Genetics of HLA-linked congenital adrenal hyperplasia. In:
B Blomberg et al (eds), Advances in Gene Technology: Molecular Biology of the Immune
System, New York, Cambridge University Press, 1985, pp 41-45.
288. Ludvigsson J, Samuelsson U, Beauforts C, Deschamps 1, Dorchy H, Drash A, Francois R,
Herz G, New M, Schober E: HLA-DR3 is associated with a more slowly progressive form
of Type I (insulin-dependent) diabetes. Diabetologia, 29:207-210, 1986. .
289. White PC, Werkmeister J, New MI, Dupont B: Steroid 21-hydroxylase deficiency and the
major histocompatibility complex. Hum Immunol 15:404-415, 1986.
290. Werkmeister JW, New MI, Dupont B, White PC: Frequent deletion and duplication of the
steroid 21-hydroxylase genes. Am J Hum Genet 39:461-469, 1986.
291. Cappa M, Stoner E, DiMartino J, Pang S, Temeck J, Gudmundsson ST, New, MI:
Heterogeneity of Cushing's disease in childhood. J Pediatr Neurosci 2:11-26, 1986.
292. Monder C, Shackleton CHL, Bradlow HL, New MI, Stoner E, lohan F, Lakshmi V: The
syndrome of apparent mineralocorticoid excess: its association with 11ß-dehydrogenase
and 5α-reductase deficiency and some consequences for corticosterone metabolism, J
Clin Endocrinol Metab 63:550-557, 1986.
293. Stoner E, Noto RA, Oberfield SE, Levine LS, New MI: Effect of acute dietary sodium
alterations in normotensive and hypertensive children. J Pediatr Endocrinol 2:81-88, 1987.
294. White PC, New MI, Dupont B: Structure of human steroid 21-hydroxylase genes. Proc
Natl Acad Sci USA, 83:5111-5115, 1986.
295. Speiser PW, New MI: Genotype and hormonal phenotype in nonclassical 21-hydroxylase
deficiency, J Clin Endocrinol Metab 64:86-91, 1987.
296. Cappa M, Stoner E, DiMartino-Nardi J, Pang S, Temeck J, New MI: Recurrence of
Cushing's disease in childhood after radiotherapy-induced remission Am J Dis Children
141: 736-740, 1987.
297. New MI: Clinical and biochemical spectrum of congenital adrenal hyperplasia: new
molecular insights. In: R D'Agata, GP Chrousos (eds), Recent Advances in Adrenal
Regulation and Function, Serono Symposia, Madrid, Spain, Sept 19-20, 1986, Raven
Press, New York, 1987, pp 171-174.
298. New MI: Basic, clinical aspects of congenital adrenal hyperplasia Proceedings of the VII
International Congress on Hormonal Steroids, Madrid, Spain, Sept 21, 1986. J Steroid
Biochem 27:1-7, 1987.
299. Nass R, Baker S, Speiser P, Virdis R, Balsamo A, Cacciari E, Loche S, Dumic M, New MI:
Hormones and handedness: Lefthand bias in female congenital adrenal hyperplasia
patients. Neurology 37:711-715, 1987.
2/1/95
LIST OF PUBLICATIONS
25
MARIA I. NEW
300. Committee of the Second International Symposium on Hypertension in Children, (MI New,
Committee Member) Recommendations for blood pressure measurement in children and
adolescents. In: IH Slater (ed), Clinical and Experimental Hypertension. In: K Scharer, W
Rascher, D Gantem, U Laaser (eds), Proceedings of the Second International Symposium
on Hypertension in Children-and Adolescents, Oct 11-12, 1985, Heidelberg, FRG, Vol A8,
No 4, 5, Marcel Dekker, New York, 1986, pp 901-918.
301. Lahita RG, Bradlow HL, Ginzler E, Pang S, New MI: Low plasma androgens in women
with systemic lupus erythematosus. Arthr Rheumat 30:241-248, 1987.
302. New MI: HLA and adrenal disease. In: NR Farid (ed), Immunogenetics of Endocrine
Disorders, Alan R Liss, New York, 1988, pp 309-344.
303. Drucker S, Speiser PW, New MI: Hereditary aspects of defects in synthesis of adrenal
hormones. In: DR Hollingsworth and R Resnik (eds), Medical Counseling Before
Pregnancy, Churchill, Livingstone, New York, 1988, pp 193-209.
304. New MI: Molecular genetics and the characterization of steroid 21-hydroxylase deficiency.
Endocrine Res 12:505-522, 1986.
305. Nass R, Engel M, Stoner E, Pang S, New MI: Empty sella syndrome in childhood. Pediatr
Neurol 2:224-228, 1986.
306. Drucker S, New MI: Disorders of adrenal steroidogenesis. Ped Clin N Am 34: 1055-1066,
1987.
307. Drucker S, New MI: Nonclassic adrenal hyperplasia due to 21-hydroxylase deficiency.
Ped Clin No Amer 34:1067-1081, 1987.
308. Pang S, Pollack MS, Loo M, Green O, Nussbaum R, Clayton G, Dupont B, New MI:
Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
In: BL Therrell Jr (ed), Advances in Neonatal Screening. In: Excerpta Medica International
Congress Series 741, Amsterdam, 1987, pp 273-278.
309. Pang S, Softness B, Sweeney WJ III, New MI: Hirsutism, polycystic ovarian disease, and
ovarian 17-ketosteroid reductase deficiency. New Engl J Med 316:1295-1301, 1987.
310. DiMartino-Nardi J, Stoner E, Martin K, Balfe JW, Jose PA, New MI: New findings in
apparent mineralocorticoid excess. Clin Endocrinol 27:49-62, 1987.
311. Zerah M, Pang S, New MI: Morning salivary I7-hydroxyprogesterone is a useful screening
test for nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 65:227-232,
1987.
312. Pang S, Legido A, Levine LS, Temeck JW, New MI: Adrenal androgen response to
metyrapone, adrenocorticotropin, and corticotropin-releasing hormone stimulation in
children with hypopituitarism. J Clin Endocrinol Metab 65: 282-289, 1987.
2/1/95
LIST OF PUBLICATIONS
26
MARIA I. NEW
313. Döhler K-D, New MI: Sexualentwicklung. In: RD Hesch (ed), Innere edizin der
Gegewnwart, vol IV: Endokrinologie, Urban and Schwarzenberg, München, 1989, pp 501-
512.
314. Temeck J, Pang S, New MI: Congenital adrenal hyperplasia. In: W Bardin (ed), Current
Therapy in Endocrinology and Metabolism, 3rd edition, BC Decker Inc, Philadelphia, 1988,
pp 143-48.
315. New MI, Drucker S, Speiser P: Nonclassical steroid 21-hydroxylase deficiency as a cause
of reproductive dysfunction. In: SS Wachtel (ed), Evolutionary Mechanisms in Sex
Determination, CRC Press, Florida, 1989, pp 253-264.
316. White PC, New MI, Dupont B: Congenital adrenal hyperplasia. New Engl J Med
316:1519-1524, 1580-1586, 1987.
317. New MI, Speiser PW: Congenital adrenal hyperplasia, In: CGD Brook (ed), Clinical
Paediatric Endocrinology, Blackwell Scientific, Oxford, 1989, pp 441-462.
318. Sasano H, White PC, New MI, Sasano N: Immunohistochemistry of cytochrome P-450
21-hydroxylase: microscopic examination of the enzyme in the bovine adrenal cortex and
kidney. Endocrinology 122:291-295, 1988.
319. New MI, White PC, Pang S, Dupont B, Speiser PW: The adrenal hyperplasias, In: CR
Scriver, AL Beaudet, WS Sly and D Valle (eds), The Metabolic Basis of Inherited Disease,
6th edition, McGraw-Hill, New York, 1989, pp 1881-1917.
320. Sherman SL, Aston CE, Morton NE, Speiser PW, New MI: A segregation and linkage
study of classical and nonclassical 21-hydroxylase deficiency. Am J Hum Genet
42:830-838, 1988.
321. Aston CE, Sherman SL, Morton NE, Dupont B, Speiser PW, New MI: Genetic mapping of
the 21-hydroxylase locus: estimation of small recombination frequencies. Am J Hum
Genet 43:304-10, 1988.
322. Amor M, Parker KL, Globerman H, New MI, White PC: Mutation in the CYP21 gene lle-
172 - causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 85:1600-1604,
1988.
323. Globerman H, Amor M, Parker KL, New MI, White PC: A nonsense mutation causing
steroid 21-hydroxylase deficiency. J Clin Invest 82:139-44, 1988.
324.
New MI: Congenital adrenal hyperplasia. Biochem Soc Trans 16:691-694, 1988.
2/1/95
LIST OF PUBLICATIONS
27
MARIA I. NEW
325. New MI, Speiser PW: Disorders of adrenal steroidogenesis. In: ED Vaughan and RM
Carey, (eds), Adrenal Disorders, New York, Thieme Medical, 1989, pp 191-217.
326. New MI, Crawford C: Low renin hypertension in childhood. In: F Lifshitz (ed), Pediatric
Endocrinology, 2nd Ed, New York, Marcel Dekker, 1990, pp. 921-935.
327. Speiser PW, New MI: An update of congenital adrenal hyperplasia. In: F Lifshitz (ed),
Pediatric Endocrinology, 2nd Ed, New York, Marcel Dekker, 1990, pp. 307-331.
328. New MI, Brown P, Temeck JW, Owens C, Hedley-Whyte ET, Richardson EP: Preclinical
Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient.
Neurology 7:1133-4, 1988.
329. White, PC, Vitek A, Dupont B, New MI: Characterization of frequent deletions causing
steroid 21-hydroxylase deficiency. Proc Nat Acad Sci USA 85:4436-4440, 1988.
330. New MI, Nemery RL, Chow DM, Kaufman ED, Stoner E, Zerah M, Crawford C, Speiser
PW: Low-renin hypertension of childhood. In: F Mantero, R Takeda, BA Scoggins, EG
Biglieri, JW Funder (eds), The Adrenal and'Hypertension: from Cloning to Clinic.
Ares-Serona Symposia, No 57, Tokyo, July 25-26, 1988, Raven Press, New York, 1989,
pp 323-343.
331. Speiser PW, New MI, White PC: Molecular genetic analysis of nonclassic steroid
21-hydroxylase deficiency associated with HLA-B14;DR1. New Engl J Med 319:19-23,
1988.
332. New MI, White PC, Speiser PW, Crawford C, Dupont B: Congenital adrenal hyperplasia.
In: CRW Edwards and DW Lincoln, eds. Recent Advances in Endocrinology and
Metabolism, vol 3, New York, Churchill, Livingstone, 1989, pp 29-76.
333. New MI, White PC, Dupont B, Crawford C, Speiser PW: Congenital adrenal hyperplasia.
In: Endocrinology and Metabolism In-Service Training and Continuing Education Program.
Washington DC, The American Association for Clinical Chemistry, vol 6, 1988, pp 5-19.
334. New MI, White PC, Speiser PW, Crawford C, Dupont B: Congenital adrenal hyperplasia.
In: AEH Emery and DL Rimoin (eds), Principles and Practice of Medical Genetics, 2nd
Ed., New York, Churchill, Livingstone, 1990, pp 1559-1591.
335. Anderson KE, Rosner W, Khan MS, New MI, Pang S, Wissel PS, Kappas A:
Diet-hormone interactions: protein/carbohydrate ratio alters reciprocally the plasma levels
of testosterone and cortisol and their respective binding globulins in man. Life Sciences
40: 1761-1768, 1988
336. New MI, Josso N: Disorders of gonadal differentiation and congenital adrenal hyperplasia.
In: WF Young Jr and GG Klee (eds), Diagnostic Evaluation of Endocrine Disorders. In:
Endocrinology and Metabolism Clinics of North America, vol. 17, WB Saunders Co,
Philadelphia, 1988, pp 339-366
2/1/95
LIST OF PUBLICATIONS
28
MARIA I. NEW
337.
338. Britton H, Shebab Z, Lightner E, New M, Chow D: Adrenal response in children receiving
high doses of ketoconazole for systemic coccidioidomycosis. J Pediatr 112:488-92, 1988.
339. New MI, Gertner JM, Speiser. PW, del Balzo P: Growth and final height in classical and
nonclassical 21-hydroxylase deficiency. Acta Paediatr Jpn 39: 79-88, 1989.
340. Globerman H, Rösler A, Theodor R, New MI, White PC: An inherited defect in aldosterone
biosynthesis caused by a mutation in or near the gene for steorid 11-hydroxylase. N Engl
J Med 319:1193-1197, 1988.
341. New MI: Optimal treatment of adrenogenital syndrome. In: Syllabus of The Endocrine
Society 40th Annual Postgraduate Assembly, Phila, Pa, 1988, p 272-289.
342. Sasano H, White PC, New MI, Sasano N: Immunohistochemical localization of
cytochrome P-450C21 in human adrenal cortex and its relation to endocrine function.
Human Pathology 19:181-5, 1988.
343. Speiser PW, New MI, White PC: Clinical and genetic characterization of nonclassic
21-hydroxylase deficiency. Endocrine Res 15: 257-276, 1989.
344. Globerman H, Pang S, Selfe RW, New MI, Grabowski E, Feliz J, Hurley JR: Eosinophilic
granuloma presenting as hypothyroidism and goiter. J Pediatr Endocrinol 3:181-184,
1989.
345. Speiser PW, Stoner E, White PC, Crawford C, New MI: Steroid modulation of blood
pressure and mineralocorticoid hypertension. In: JMH Loggie (ed), Pediatric and
Adolescent Hypertension, Chap 5, Blackwell Scientific Publications, Cambridge, 1992, pp
64-73.
346. New MI, White PC, Speiser PW, Crawford C, Dupont B: Genetic disorders of adrenal
hormone synthesis. In: Proceedings of the 8th International Congress of Endocrinology,
Kyoto, 17-23 July 1988. Excerpta Medica, Intnl Congr Ser, vol 799: Amsterdam, Elsevier
pp 55-72, 1988.
347. New MI, del Balzo P, Crawford C, Speiser PW: The adrenal cortex. In: SA Kaplan (ed),
Clinical Pediatric and Adolescent Endocrinology, Philadelphia, WB Saunders, 1989, pp
181-234.
348. New MI, Speiser PW, Crawford C, White PC: Inborn errors of steroidogenesis. In: JR
Pasqualini, R Scholler (eds), Hormones and Fetal Physiology, New York, Marcel Dekker,
1992, pp 1-51.
349. New MI, del Balzo P, Schnakenburg KV: Diseases of the anterior and posterior pituitary.
In: H Eichenwald, J Stroder (eds), Current Therapy in Pediatrics, vol 2, BC Decker,
Burlington, Ontario, 1988, pp 223-225.
2/1/95
LIST OF PUBLICATIONS
29
MARIA I. NEW
350. New MI, del Balzo P, Schnakenburg KV: Disorders of the adrenal. In: H Eichenwald, J
Stroder (eds), Current Therapy in Pediatrics, vol 2, BC Decker, Burlington, Ontario, 1988,
217-223.
351. New MI: Polycystic ovarian disease and congenital and late-onset adrenal hyperplasia.
In: JK Mahajan (ed), Polycystic Ovarian Disease, In: Endocrinology and Metabolism
Clinics of North America, vol 17, December, 1988.
352. New MI, Gertner JM, Speiser PW, del Balzo P: Final height in classical and nonclassical
21-hydroxylase deficiency adrenal hyperplasia. In: JR Bierich, E Cacciari, S Raiti (eds),
Growth Abnormalities, vol. 56. Serono Symposia, Bologna, June 1988, Raven Press,
1989, pp 51-61.
353. White PC, New MI: Molecular genetics of congenital adrenal hyperplasia. In: M Sheppard
(ed), Molecular Biology of Endocrinology, In: Bailliere's Clinical Endocrinology and
Metabolism, vol 2, WB Saunders/Bailliere Tindall, London, 1988, pp 941-965.
354. Shulman DI, Vargas A, Rodriguez, Steinberger E, New MI, Root AW, Bercu BB: Male
pseudohermaphroditism and hypertension due to 17α-hydroxylase deficiency:* seven year
follow up and in vitro studies of testicular tissue. J Ped Endocrinol 2:89-95, 1987.
355. Speiser PW, White PC, New MI: Disorders of adrenal steroidogenesis. In: RA King, JI
Rotter, AG Motulsky (eds), Chap 24. The Genetic Basis of Common Diseases, Oxford
University Press, New York, 1992, pp 529-550.
356. New MI: Adrenal hyperplasia and endocrine infertility. In: Endocrinology and Infertility
Update: Current Trends and New Horizons. Conference sponsored by Columbia
University and Sloane Hospital for Women, The Presbyterian Hospital. New York, March
30-Apr 1, 1989, pp 221-238.
357. New MI: Disturbi della corteccia surrenale in adulti e bambini. Leadership Medica (Milan)
4: 4-8, 1988.
358. Rosenfeld RG, Hintz RL, Johanson AJ, et al.: Results from the first 2 years of a clinical
trial with recombinant DNA-derived human growth hormone (somatrem) in Tumer's
syndrome. Acta Paediatr Scand [Suppl] 331:59, 1987.
359. Wilson DM, Frane JW, Sherman B, Johanson J, Hintz RL, Rosenfeld RG, Brasel J,
Burstein S, Chernausek SD, Gotlin RW, Kuntze J, Lippe BM, Mahoney PC, Moore WV,
New MI, Saenger P, Sybert V: Carbohydrate and lipid metabolism in Tumer syndrome:
effect of therapy with growth hormone, oxandrolone, and a combination of both. J
Pediatrics 112:210-217, 1988.
360. Rosenfeld RG, Hintz RL, Johanson AJ, Sherman B, Brasel JA, Burstein S, Chernausek S,
Compton P, Frane J, Gotlin DW, Kuntze J, Lippe RM, Mahoney PC, Moore WV, New MI,
Saenger P, Sybert V: Three-year results of a randomized prospective trial of methionyl
human growth hormone and oxandrolone in Turner syndrome. J Pediatrics 113: 393-400,
1988.
2/1/95
LIST OF PUBLICATIONS
30
MARIA I. NEW
361. Burstein S, Crawford C, New MI: Congenital adrenal hyperplasia: female
pseudohermaphraoditism and virilization. In: L Speroff and JL Simpson (eds),
Reproductive Endocrinology, Infertility, Genetics, Vol. 5, Series 55, In: JJ Sciarra (ed),
Gynecology and Obstetrics, Chap 78, JB Lippincott Co, Phila, 1991. pp 1-21.
362. New MI, Gertner JM, Speiser PW, del Balzo P: Growth and final height in classical and
nonclassical 21-hydroxylase deficiency. J Endocrinol Invest 12:91-95, 1989.
363. White PC, Crawford C, New MI: Steroid 21-hydroxylase deficiency, Current Opinion in
Pediatrics 1: 436-440, 1989.
364. Speiser PW, Laforgia N, Kato K, Pareira J, Khan R, Yang SY, Whorwood C, White PC,
Elias S, Schriock E, Schriock E, Simpson JL, Taslimi M, Najjar J, May S, Mills G, Crawford
C, New MI: First trimester prenatal treatment and molecular genetic diagnosis of
congenital adrenal hyperplasia (21-hydroxylase deficiency). J Clin Endocrinol Metab
70:838-848, 1990.
365. Zerah M, Ueshiba J, Wood E, Speiser P, Crawford C, McDonald T, Pareira J, Gruen D,
New MI: Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a
morning salivary 17-hydroxyprogesterone screening test: a small sample study. J Clin
Endocrinol Metab 70:1662-1667, 1990.
367. Burstein S, New MI: Commentary. Pediatr Infect Dis J 8:19-20, 1989.
368. White PC, New MI, Dupont B: Congenital adrenal hyperplasia. (Letter to the Editor) New
Engl J Med 317: 1413-1415, 1987.
369. New MI, Karaviti L: Congenital adrenal hyperplasia. In: CW Bardin (ed), Current Therapy
in Endocrinology and Metabolism, BC Decker Inc, Philadelphia, 1991, pp 141-151.
370. New MI: Nonclassical 21-hydroxylase deficiency. In: Polycystic Ovary Syndrome, In: A
Dunaif, J Givens, G Merriam, FP Haseltine (eds), Current Issues in Endocrinology and
Metabolism Series, Blackwell Scientific, Cambridge, 1992, pp 145-161.
371. Speiser PW, Levine LS, New MI: Essential hypertension in childhood and adolescence.
In: JJ Laragh, E Sonnenblick, S Scheidt (eds), Cardiovascular Reviews & Reports,
"Classics of the Decade Series", 1990, pp 10-42.
372. New MI: Congenital adrenal hyperplasia. In: RB Conn (ed), Current Diagnosis 8, WB
Saunders, Phila, 1991, pp 876-881.
5/28/96
LIST OF PUBLICATIONS
31
MARIA 1. NEW
374. New MI: Nonclassical 21-hydroxylase deficiency. In: Proceedings of the RM Goodman
International Conference, Israel June 1990. In: B Bonne-Tamir, A Adam (eds), Genetic
Diversity among Jews. Diseases and Markers at the DNA Level, Chap. 14, Oxford
University Press, London, 1992, pp 154-169.
375. New MI: Nonclassical 21-hydroxylase deficiency. In: EY Adashi, S Mancuso (eds), Major
Advances in Human Female Reproduction, vol. 73. Ares Serono Symposia, Raven Press,
New York, 1990, pp 309-315.
377. Ulick S, Chan CK, Gill JR, Gutkin M, Letcher L, Mantero F, New MI: Defective fasciculata
zone function as the mechanism of glucocorticoid remediable aldosteronism. J Clin
Endocrinol Metab 71: 1151-1157, 1990.
378. Pang S, Levine LS, New MI: Puberty in congenital adrenal hyperplasia. In: M Grumbach
(ed), Control of the Onset of Puberty II. Williams & Wilkins, Baltimore, 1990, pp 669-689.
379. Dumic M, Brkljacic L, Speiser PW, Wood E, Crawford C, Plavsic V, Baniceviac M,
Radmanovic S, Radica A, Kastelen A, New MI: An update on the frequency of nonclassic
deficiency of adrenal 21-hydroxylase in the Yugoslav population. Acta Endocrinologica
122: 703-710, 1990.
380. New MI: Prenatal diagnosis and treatment of adrenogenital syndrome (steroid
21-hydroxylase deficiency). Dev Pharmacology Ther 15: 200-210, 1990.
381. Moya FR, Grannum PAT, Riddick L, Copel JA, Robert JA, Pinheiro J, New MI: Atrial
natriuretic factor in hydrops fetalis due to Rh isoimmunization. Arch Dis Childh 65:863-
868, 1990.
382. New MI: Congenital adrenal hyperplasia. Trans Am Clin Climatol Assoc 102:108-122,
1991.
383. New MI, Zerah M, Crawford C: Adrenal function and chronic anovulation. In: Chronic
Hyperandrogenic Anovulation, (Proceedings of the First Organon Symposium, Oss
Netherlands Oct 9-10, 1989, Parthenon Publishing Group, Park Ridge NJ, 1991, pp 47-54.
384. Speiser PW, Agdere L, Ueshiba H, White PC, New MI: Aldosterone synthesis in
salt-wasting congenital adrenal hyperplasia with complete absence of adrenal
21-hydroxylase. New Engl J Med 324: 145-9, 1991.
385. Zerah M, Schram P, New MI: The diagnosis and treatment of nonclassical 3β-HSD
deficiency. The Endocrinologist 1: 75-81, 1991.
5/28/96
LIST OF PÚBLICATIONS
32
MARIA I. NEW
386. New MI: Congenital adrenal hyperplasia and reproduction. In: (Syllabus) Frontiers in
Reproductive Endocrinology, Serono Symposia, USA, April 22-26, 1991, pp 49-59.
387. New MI, Karaviti LP, Crawford C: Disorders of the adrenal gland. In: FD Burg, JR
Ingelfinger, ER Wald (eds), Current Pediatric Therapy 14, WB Saunders, Philadelphia,
1993, pp 292-296.
388. Tusie-Luna MT, Speiser PW, Dumic M, New MI, White PC: A mutation (Pro-30 to Leu) in
CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol
Endoc 5: 685-692, 1991.
389. Speiser PW, Serrat J, New MI, Gertner J: Insulin insensitivity in adrenal hyperplasia due
to nonclassical steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 75: 1421-1424,
1992.
390. Tannin GM, Agarwal AK, Monder C, New MI, White PC: The human gene for 11ß-
hydroxysteroid dehydrogenase. Structure, tissue distribution and chromosomal
localization. J Biol Chem 266: 16653-16658, 1991.
391. Speiser PW, White PC, New MI: Congenital adrenal hyperplasia. In: VHT James (ed),
Comprehensive Endocrinology - The Adrenal Gland, 2nd edition, Raven Press, New York,
1992, pp 327-371.
392. New MI, Speiser PW, Butenandt O: Diseases of the anterior and posterior pituitary. In:
HF Eichenwald, J Ströder, (eds), Current Therapy in Pediatrics - 3, Mosby-Year Book, St
Louis, 1993, pp 261-263.
393. New MI, Speiser PW, Butenandt O: Diseases of the adrenals. In: HF Eichenwald, J
Ströder, (eds), Current Therapy in Pediatrics - 3, Mosby-Year Book, St Louis, 1993, pp
252-261.
394. White PC, Dupont J, New MI, Leiberman E, Hochberg Z, Rösler A: A mutation in
CYP11B1 (Ar-448 - His) associated with steroid 11ß-hydroxylase deficiency in Jews of
Moroccan origin. J Clin Invest 87: 1664-1667, 1991.
395. White PC, New MI: Genetic basis of endocrine disease 2. Congenital adrenal hyperplasia
due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 74: 6-11, 1992.
396. Schram P, Zerah M, Mani P, Jewelewicz R, Jaffe S, New MI: Nonclassical 3β-HSD
deficiency: A review of our experience with 25 female patients. Fertil Steril 58: 129-136,
1992.
397. Karaviti LP, Mercado AB, Mercado MY, Speiser PW, Buegeleisen M, Crawford C, Antonian
L, White PC, New MI: Prenatal diagnosis/treatment in families at risk for infants with
steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia). In: Recent Advances
in Steroid Biochemistry and Molecular Biology, (10th Intnl Symposium, May, 1991, France.
J Steroid Biochem and Mol Biol 41: 445-451, 1992.
2/1/95
LIST OF PUBLICATIONS
33
MARIA 1. NEW
398. New MI: Congenital adrenal hyperplasia. The Endocrine Society 43rd PostGraduate
Assembly Syllabus, pp 270-293, 1992.
399. New MI, Gertner JM, Speiser PW, del Balzo P: Growth and final height in congenital
adrenal hyperplasia (classical 21-hydroxylase deficiency) and in nonclassical 21-
hydroxylase deficiency. In: L Cavallo, JC Job, MI New (eds), Growth Disorders: The
State of the Art, vol. 81, Raven Press, New York, 1991, pp 105-110.
400. Harbison MD, Magid ML, Josso N, Minenberg DT, New MI: Anti-Müllerian hormone in
three intersex conditions. Ann Genet 34: 226-232, 1991.
401. Lorberboym M, Sarkar SD, Speiser P, Tannin G, New MI: Bilateral adrenal uptake of
gallium-67 citrate in a patient with congenital adrenal hyperplasia. Clin Nucl Med 15:849,
1990.
402. Speiser PW, New MI, Tannin GM, Pickering D, Yang Sy, White PC: Genotype of Yupik
eskimos with congenital adrenal hyperplasia-due to 21-hydroxylase deficiency. Hum
Genet 88: 647-648, 1992.
403. Speiser PW, Dupont J, Zhu D, Serrat G, Buegeleisen M, Tusie-Luna M-T, Lesser M, New
MI, White PC: Disease expression and molecular genotype in congenital adrenal
hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90: 584-595, 1992.
404. Johnson V, New MI: If the stimulus to pituitary thyroid-stimulation hormone (TSH)
secretion is the lack of circulating free thyroxine, why may a baby with congenital nephrotic
syndrome present with a raised TSH on neonatal screening? Pediatr Nephrolog 6:458,
1992.
405. New MI: Pathophysiology of adrenal steroidogenesis. In: P Gluckman, M A Heyman
(eds) Perinatal and Pediatric Physiology - a Clinical Perspective, 1st edition, Hodder and
Stoughton Ltd, London, 1993, pp.326-329.
406. New MI: Genetic disorders of adrenal hormone synthesis. In: Proceedings, International
Symposium - Endocrinology and Development, Basic and Clinical Aspects, Athens, Oct
1990, Hor Res 37: 22-33. 1992.
407. New MI: The variants of adrenal hyperplasias. In: Reproductive Medicine, G Frajese, E
Steinberger, LJ Rodriguez-Rigau (eds), Proceedings of the Third International Symposium
on Reproductive Medicine, Malta, April, 1992, Ares Serona Symposium Series, Raven
Press, pp 173-184, 1993.
408. Speiser PW, White PC, New MI: Congenital adrenal hyperplasia. In: SK Smith (ed),
Reproductive Medicine Review, vol. 2, Hodder & Stoughton, Kent UK, pp 1-13, 1993.
409. Speiser PW, Riddick LM, Martin K, New MI: Investigation of the mechanism of
hypertension in apparent mineralocorticoid excess. Metabolism 42: 1-4, 1993.
2/1/95
LIST OF PUBLICATIONS
34
MARIA I. NEW
410. Ueshiba J, Zerah M, New MI: Enzyme-linked Immunosorbent assay (ELISA) method for
screening of non-classical steroid 21-hydroxylase deficiency. Horm Metab Res 26: 43-45,
1994.
411. New, MI: Congenital virilizing adrenal hyperplasia. In: EY Adashi, JA Rock, Z
Rosenwaks (eds), Reproductive Endocrinology, Surgery, and Technology, Raven Press,
New York (in press) 1995.
412. New MI: Prenatal diagnosis and management of congenital adrenal hyperplasia. In:
Proceedings of the International Sardinian Congr. on Pediatric Endocrinology, Porto Cervo,
Oct. 1990. In: C Pintor, S Loche, EE Muller, MI New, (eds), Advances in Pediatric
Endocrinology, Springer Verlag, Berlin, 1992, pp 13-16.
413. Speiser PW, New MI, White PC: Congenital Adrenal Hyperplasia. In: RD Weintraub (ed),
Molecular Endocrinology: Basic Concepts and Clinical Correlations. Raven Press, New
York, pp 455-472, 1994.
414. Kidd K, Kidd JR, Bonné-Tamir B, New MI: Nuclear DNA polymorphisms and population
relationships. In: Proceedings of the RM Goodman International Conference, Israel June
1990. In: B Bonne-Tamir, A Adam (eds), Genetic Diversity among Jews. Diseases and
Markers at the DNA Level, Chap. 2, Oxford University Press, London, 1992, pp 33-44.
415. Carré-Eusebe D, Imbeaud S, Harbison M, New MI, Josso N, Picard J-Y: Variants of the
anti-Müllerian hormone gene in a compound heterozygote with the persistent Müllerian
duct syndrome and his family. Human Genetics 90: 389-394, 1992.
416 New MI, Crawford C: Female pseudohermaphroditism. In: N Charest (ed), Sexual
Differentiation. In: BK Creasy and JB Warshaw (eds), Seminars in Perinatology, vol 16,
WB Saunders Co, Philadelphia, pp 299-318, 1992.
417. Rhéaume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, New MI, Labrie F:
Congenital adrenal hyperplasia due to point mutations in the type II 3ß-hydroxysteroid
dehydrogenase gene. Nature Genetics 1:239-245, 1992.
418. New MI: Minireview: 21-hydroxylase deficiency congenital adrenal hyperplasia. J Ster
Biochem Molec Biol 48: 15-22, 1994.
419. New MI: Nonclassical congenital adrenal hyperplasia and PCO. In: Chrousos GP, et al
(eds), Intraovarian Regulators and Polycystic Ovarian Syndrome: Recent Progress on
Clinical and Therapeutic Aspects. Proceedings of the Satellite Symposium to the 9th
International Congress of Endocrinology, Aug 24-26, 1992, Athens, Greece. Ann NY Acad
Science, 687: 193-205, 1993.
420. Simard J, Rhéaume E, Sanchez R, deLaunoit, Laflamme N, Luu-The Vᵣ van Seters A,
Gordon RD, Heinrich U, Moshang T, New MI, Labrie F: Molecular basis of congenital
adrenal hyperplasia due to 3β-HSD. Molecular Endocrinology 7:716-728, 1993.
2/1/95
LIST OF PUBLICATIONS
35
MARIA I. NEW
421. New MI, Kitzinger ES: Pope Joan: A recognizable syndrome. J Clin Endo Metab 76: 3-
13, 1993.
422. New MI: Congenital adrenal hyperplasia. In: LJ DeGroot, M Besser, HG Burger, JL
Jameson, DL Loriaux, JC Marshall, WD Odell, JT Potts Jr, AH Rubenstein (eds),
Endocrinology, 3rd edition, W.B. Saunders Co, Philadelphia, 1995 pp 1813-1835.
423. New MI: Pope Joan: A recognizable syndrome. Trans Am Clin Climatol Assoc, 104: 104-
122, 1993.
424. Nikkilä H, Tannin GM, New MI, Taylor NF, Kalaitzoglou G, Monder C, White PC: Defects
in the HSD11 gene encoding 11 β-hydroxysteroid dehydrogenase are not found in patients
with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J Clin Endocrinol
Metab 77:687-691, 1993
425. Pascoe L, Curnow KM, Slutsker L, Connell JMC, Speiser PW, New MI, White PC:
Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by
unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci USA 89:8327-
8331, 1992.
426. Kalaitzoglou G, New MI: Congenital Adrenal Hyperplasia: Molecular Insights Learned from
Patients. University of California at Riverside Symposium on Cellular and Molecular
Endocrinology, March 1993, AW Norman, Guest Editor, Receptor 3: 211-222, 1993.
427. Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, White PC, Pascoe L:
Mutations in the CYP11B1 gene causing congential adrenal hyperplasia and hypertenison
cluster in exons 6, 7, and 8. Proc Natl Acad Sci USA 90:4552-4556, 1993.
428. Antonian L, Rittmaster RS, Davis EA, Ma Y, New MI, Stoner E: Chromatographic profile
of 3H-finasteride, a 5α-reductase inhibitor, on Abraham's celite columns. Clin Chem News
19: 17-18, 1993.
429. New MI, Crawford C: Molecular genetics of steroid 21-hydroxylase deficiency. In: S
Wachtel (ed), Molecular Genetics of Sex Determination, Chap 17, Academic Press, New
York, 1994, pp 399-438.
430. Rittmaster RS, Antonian L, New MI, Stoner E: Effect of finasteride on adrenal
steroidogenesis in men. J Andrology 15: 298-301, 1994.
431. New MI, Tannin G, Curtis JA, Vogiatzi M: Enzyme defects and adrenal insufficiency. In:
H R Bhatt, VHT James, GM Besser, GF Bottazzo, H Keen (eds), Advances in Thomas
Addison's Diseases, J Endocrinology Ltd, 1994, pp 163-164. Proceedings, Thomas
Addison and His Diseases: 200 Years International Symposium held in Padua, May 1993,
J Endocrinology Ltd, Bristol, UK.
4/2/96
LIST OF PUBLICATIONS
36
MARIA I. NEW
432. New MI: Apparent mineralocorticoid excess: A personal history. In: W Rosner, RB
Hochberg, (eds), Proceedings, First Symposium on 11ß-hydroxysteroid-dehydrogenase,
Kulturzentrum Appenberg, Bern, June 1993, Steroids 59: 66-68, 1994.
433. New MI, Crawford C, Cheng KC, Wilson R: Inborn errors of steroidogenesis. In: Ares
Serono International Symposium on Cell and Molecular Biology of the Testis, held in
Majorca Spain, Sept 1993, In: Challenges in Endocrinology and Modem Medicine, Serono
Symposia Publications, Rome, (in press) 1996.
434. Speiser PW, White PC, Dupont J, Zhu D, Mercado A, New MI: Molecular genetic prental
diagnosis of congenital adrenal hyerplasia due to 21-hydroxylase deficiency by allele-
specific hybridization. Rec Prog Horm Res 49: 367-371, 1994.
435. Speiser PW, White PC, Dupont J, Zhu D, Mercado A, New MI: Prenatal diagnosis of
congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific
hybridization and Southern blot. Human Gen 93: 424-428, 1994.
436. Speiser PW, New MI: Hormonal hypertension in childhood. In: N Lavin (ed), Manual of
Endocrinology and Metabolism, Little Brown and Co, Boston, pp 161-173, 1994.
437. New, M.I.: Managment of pain in hospitalized children. In: F Angelini (ed), Proceedings,
Eighth International Conference, Puer natus est nobis: The Child is the Future of Society,
Vatican City, November 1993; Trattamento del dolore nei bambini ospedalizzati.
Dolentium Hominum, 9: 274-275, 1994.
438. New MI: Congenital adrenal hyperplasia. In: Proceedings, International Symposium on:
Molecular Basis of Endocrine Diseases, Barcelona, November, 1993, In: Frontiers in
Endocrinology, Vol 7, Serono Symposia Publication, Rome 1994, pp 55-73.
439. Huma Z, Crawford C, New MI: Congenital adrenal hyperplasia. In: CJD Brook (ed),
Clinical Paediatric Endocrinology, 3rd edition, Chap 30, Blackwell Scientific, London, 1995
pp 536-557.
440. Wigley WC, Prihoda JS, Mowszowicz I, Mendonca BB, New MI, Wilson JD, Russell DW:
Natural mutagenesis study of the human steroid 5α-reductase 2 isozyme. Biochemistry
33: 1265-1270, 1994.
441. Qin K-N, New MI, Cheng K-C: Moleuclar cloning of multiple cDNAS encoding human
enzymes structurally related to 3α-hydroxysteroid dehydrogenase. J Steroid Biochem
Molec Biol 46: 673-679, 1994.
442. Speiser PW, New MI: Prenatal diagnosis and management of congenital adrenal
hyperplasia. In: G Koren, S Ito (eds), Fetal Drug Therapy. In: S Hitchens (ed), Clinics in
Perinatology, WB Saunders Co, Philadelphia, 1994 pp 631-645.
4/2/96
LIST OF PUBLICATIONS
37
MARIA I. NEW
443. New MI, Mercado AB, Wilson RC: Prenatal hormonal therapy correcting genital ambiguity
in adrenal steroid 21-hydroxylase deficient genetic females. Proceedings, 1st Asian-
Pacific Regional Meeting of International Society for Neonatal Screening, June 21-23,
1993, Sapporo. In: N Takasugi and H Naruse (eds). New Trends in Neonatal Screening,
Hokkaido Univ. Press, Sapporo, 1994, pp 111-116.
444. Bichet DG, Bimbaumer M, Lonergan M, Arthus M-F, Rosenthal W, Goodyer P, Nivet H,
Benoit S, Giampietro P, Simonetti 'S, Fish A, Whitley CB, Jaeger P, Gertner J, New MI,
DiBona FJ, Kaplan BS, Robertson Gl, Hendy, GN, Fujiwara TM, Morgan K: Nature and
recurrence of AVPR2 mutations in x-linked nephrogenic diabetes insipidus. Am J Human
Gen 55:278-286, 1994.
445. New MI, Ghizzoni L, Speiser PW: An update of congenital adrenal hyperplasia. In: F
Lifshitz (ed), Pediatric Endocrinology, chapter 16, 3rd Ed, Marcel Dekker, New York, 1995,
pp 305-320.
446. New MI, Crawford C, Virdis R: Low renin- hypertension in childhood. In: F Lifshitz (ed),
Pediatric Endocrinology, chapter 53, 3rd Ed, Marcel Dekker, New York, 1995, pp 775-789.
447. Loche S, New MI: Adrenal hyperplasia. In: GP Redmond (ed), Androgenic Disorders,
Raven Press, New York, 1995, pp 191-212.
448. Speiser PW, New MI: Prenatal diagnosis and treatment of congenital adrenal hyperplasia.
J Ped Endocrinol 7:183-191, 1994.
449. White PC, Tusie-Luna MT, New MI, Speiser PW: Mutations in steroid 21-hydroxylase
(CYP21). Human Mutation 3:373-378, 1994.
450. New MI: The prismatic case of apparent mineralocorticoid excess. J Clin Endocrinol
Metab 79:1-3, 1994.
451. Mercado AB, Wilson RC, Cheng KC, Wei J-Q, New MI: Extensive personal experience
with prenatal diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase
deficiency. J Clin Endocrinol Metab 80: 2014-2020, 1995.
452. New MI: Steroid 21-hydroxylase deficiency (Congenital adrenal hyperplasia). Am J Med
"98 (Suppl 1A), 1A1S-1A8S, 1995.
453. New MI, Josso N: Disorders of sexual differentiation, In: J Claude Bennett, F Plum, Cecil
Textbook of Medicine, 20th Edition, WB Saunders Co, Philadelphia, 1996, (in press).
454. New MI, C Crawford, RC Wilson: Genetic disorders of the adrenal steroidogenic enzymes.
In: AEH Emery and D Rimoin (eds), Principles and Practice of Medical Genetics, 3rd
Edition, New York, Churchill, Livingstone, 1996, (in press).
4/2/96
LIST OF PUBLICATIONS
38
MARIA I. NEW
455. New MI, White PC: Genetic disorders of steroid metabolism. In: R Thakker (guest
editor), Genetic and Molecular Biological Aspects of Endocrine Disease. In: KGMM Alberti,
HG Burger, RD Cohen, MB Ranke (Series editors) Baillière's Clinical Endocrinology and
Metabolism, Baillière Tindall, London, 1995, pp 525-554.
456. Trautman PD, Meyer-Bahlberg HFL, Postelnek J, New MI: Effects of early prenatal
dexamethasone on the cognitive and behavioral development of young children: results of
a pilot study. Psychoendocrinology 20: 439-449, 1995.
457. Zerah M, Rhéaume E, Mani P, Schram P, Simard J, Labrie F, New MI: No evidence of
mutations in the.genes for type I and type II 3BHSD deficiency. J Clin Endocrinol Metab
79: 1811-17, 1994.
458. Wilson RC, Wei J-Q, Chang KC, Mercado A, New MI: Rapid DNA analysis by allele-
specific PCR for detection of mutations in the steroid 21-hydroxylase gene. J Clin
Endocrinol Metab 80: 1635-1640, 1995.
459. New MI, Mercado AB, Cheng KC, Jackowski M, Wilson RC: Steroid synthesis disorders:
genotype may not predict phenotype. In: MI New (ed), Where Phenotype Does Not Match
Genotype, In: Frontiers in Endocrinology, Ares-Serono Symposia Series, vol. 16, Rome,
1996, pp. 17-27.
460. Pascoe L, Curnow KM, New MI, Corvol P: The relationship between phenotype and
genotype in glucocorticoid suppressible hyperaldosteronism (GSH). In: MI New (ed),
Where Phenotype Does Not Match Genotype, In: Frontiers in Endocrinology, Ares-Serono
Symposia Series, vol. 16, Rome, 1996, pp. 69-79.
461. Simard J, Rhéaume E, Sanchez R, Mebarki F, Morel Y, Zerah M, New MI, Labrie F:
Relation between molecular defect and phenotypic manifestation of human 3ß-
hydroxysteroid dehydrogenase deficiency. In: MI New (ed), Where Phenotype Does Not
Match Genotype, In: Frontiers in Endocrinology, Ares-Serono Symposia Series, vol. 16,
Rome, 1996, pp. 39-68.
462. New MI, Rapaport R: The adrenal cortex, In: MA Sperling (ed), Clinical Pediatric
Endocrinology, Chap.20, WB Saunders, Philadelphia, 1996, (in press).
463. Giardina PJ, Schneider R, Lesser M, Simmons B, Rodriguez A, Gertner J, New M,
Hilgartner M: Abnormal bone metabolism in thalassemia. In: S Andò et al. (eds),
Endocrine Disorders in Thalassemia, Springer-Verlag, Heidelberg, 1995, pp 39-46.
464. Wilson RC, Mercado AB, Cheng KC, New MI: Steroid 21-hydroxylase deficiency:
genotype may not predict phenotype. J Clin Endocrinol Metab 80: 2322-2329, 1995.
465. New MI: Congenital adrenal hyperplasia, In: A Isidori, MI New, CP Sesma (eds),
Molecular Basis of Endocrine Diseases, Intl Symposium, Rome, November 18-19, 1993,
In: Ares-Serona Symposia Series-Frontiers in Endocrinology, vol 7, 1994, pp. 55-74.
5/1/96
LIST OF PUBLICATIONS
39
MARIA 1. NEW
466. New MI, Newfield R: Congenital adrenal hyperplasia. In: CW Bardin (ed), Current
Therapy in Endocrinology and Metabolism 6th edition, Mosby-Year Book, Phila, (in pess)
1996.
467. Wilson RC, Krozowski ZS, LiK, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, Wei
JQ, Shackleton CHL, Funder JW, New MI: A mutation in the HSD11B2 gene in a family
with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80: 2263-2266, 1995.
468. Andersson S, Geissler WM, Wu L, Davis DL, Grumbach MM, New MI, Schwarz HP,
Blethen SL, Mendonca BB, Bloise W, Witchel SF, Cutler GB Jr, Griffin JE, Wilson JD,
Russell DW: Molecular genetics and pathophysiology of 17ß-hydroxysteroid
dehydrogenase 3 deficiency. J Clin Endocinol Metab 81: 130-136, 1996.
469. Speiser PW, Heier L, Serrat J, New MI, Nass R: Failure of steroid replacement to
consistently normalize pituitary function in congenital adrenal hyperplasia: hormonal and
MRI data. Hormone Research 44: 241-246, 1995.
470. New MI, Schram P: Congenital adrenal hyperplasia. In: RB Conn, WZ Borer, JW Snyder
(eds), Current Diagnosis 9, WB Saunders, Phila, 1996, (in press).
471. Wilson RC, Harbison MD, Krozowski ZS, Funder JW, Shackleton CH, Hanauske-Abel HM,
Wei J-Q, Hertecant J, Moran A, Neiberger RE, Balfe JW, Fattah A, Daneman D, Licholai
T, New MI: Several homozygous mutations in the HSD11B2 gene in patients with
apparent mineralocorticoid excess. J Clin Endocrinol Metab 80: 3145-3150, 1995.
472. Obeyesekere VR, Ferrari P, Andrews RK, Wilson RC, New MI, Funder JW, Krozowski ZS:
The R337C mutation generates a high Km 11 β-hydroxysteroid dehydrogenase type II
enzyme in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80:
3381-3383, 1995.
473. New MI, Dluhy RG: Steroid enzymatic abnormalities relating to hypertension. In: M
Sznajderman, W Januszewicz, A Januszewicz (eds), Hormonal Hypertension, Chap 3,
Springer-Verlag, (in press) 1996.
474. New MI: Congenital Adrenal Hyperplasia. Syllabus, Amer Assoc Clin Endocrinol 5th Ann
Mtg, Seattle, May 1-5, 1996. Annual Meeting, (in press) 1996.
475. New MI: Infertility and androgen excess in nonclassical 21-hydroxylase deficiency.
Proceedings of Symposium on "The Ovary: Regulation, Dysfunction and Treatment",
Florida January 25-27, 1996. Excerpta Medica Intnl Congr Series 1106, (in press), 1996).
476. New MI: Treatment-induced hypoandrogenism in childhood and puberty in females with
virilizing (21-hydroxylase deficiency) CAH. In: F Labrie, et al., (eds), Proc Intn Symp on
DHEA Transformation into Androgens and Estrogens in Target Tissues: Intracrinology,
Quebec, Sept 13-15, 1995. J Endocrinology (suppl) (in press) 1996.
5/1/96
LIST OF PUBLICATIONS
40
MARIA I. NEW
477. Wajnrajch MP, New MI: Disorders of the adrenal gland. In: FD Burg, JR Ingelfinger, RA
Polin, ER Wald (eds), Current Pediatric Therapy 16, WB Saunders, Philadelphia, (in
press), 1996.
478. New MI, Newfield RS: 21-Hydroxylase deficiency. Proceedings of the Third International
Congress Update on Adolescent Gynecology and Endocrinology, Dec 1995, Athens. Ann
NY Acad Sci (in press) 1996.
1
479. NIH Technology Assessment Conference Panel - New MI (Panel Member): Gaucher
disease. JAMA 275: 548-553, 1996.
480. Wilson RC, New MI: Congenital adrenal hyperplasia. In: JL Jameson (ed), Textbood of
Molecular Medicine, Blackwell Scientific, London, (in press) 1996.
7/24/96
F
THE WHITE HOUSE
Feb. 1'96
Bill, Hillary and Chelsea,
We want to thank you for opening up
your home to us. It was a wonderful visit.
for you.
We think about you often and are praying
Lore,
The Nelson family
Nan Ellen, Billy, grace and Bill
DEAR HILORY,
95
THE MEMBERS OF OUR FAN
CLUB WOULD Like To PRESENT
You with THIS SHIRT AND
STAR . THE SHIRT SIGNIFIES
Here's wishing you
THE Wonew's (LUBS THAT
an old-time Christmas,
One that still embraces
MAKE UP THE COUNTY
everything that's near
COUNCIL. THE STAR IS
and dear to you.
A SYMBOL OF THE
NORTHAMPTON COUNTY COUNCIL
SHINING STAR WE FEEL
OF DEMOCRATIC women
you ARE. IT IS HANDMADE
( WAPTER OF THE HILARY RHOOM
CLINTON FAN CLUB
OF STAINED GLASS BY ONE
FLORENCE" " HONEY " PIATT
Co
OF OUR mEMBERS - RUCH STINE.
CO ORDINATORS
PATSY HEBOR
HOPE You ENJOY BOTH,
AND THAT You HAVE A
WONDERFUL CIVRISTONAS.
A Warm
Christmas Nish
Hallmark
CROWN
PRESERVATION
PHOTOCOPY
FROM THE HAILMARK DESIGN COLLEC TIONS
From an original nineteenth-century card.
Winter activities were often portrayed
II. Christmas cards during this time period
All Hafpiness be Thine this Christmastide,
Christmas whispers to our hearts
of simpler times and places
00172
And brings back favorite memories
of kind, familiar faces
0
15012 33204
9
195X 17.2
©
HALLMARK CARDS. INC
MADE IN U S A
PES PHOTO
02-71
N.C.C.D.W.
H.R.C. FAN CLUB
C/o PATSY HEBUR
2145 MIXSEU AVE
BETHLEHEN PA 18015
THE WHITE House
HILARY CLINTON
I
C/o CAPRICIA MARSHALL
I
Ew 204
1600 PENNSYUVANIA Ave
WASHINGTON DC 20500
NORMAN LEAR
PERSONAL
DETERMINED TO BE AN
ADMINISTRATIVE MARKING
INITIALS: SAB DATE: 11/15/13
May 17, 1996
Dear Hillary,
Thank you for our time together. I
loved it.
Best,
M.
NL/la
P.S. Isn't this the best way you have seen
the attached thought expressed?
Hillary Rodham Clinton
The White House
1600 Pennsylvania Avenue
2nd Floor, West Wing
Washington, D.C. 20500
SEE
Fu
Dear Hillary,
It has been 24 years, but you still remember, the kid in the
monkey-suit, the clerk with the strained muscle, the young
staffer in the McGovern office in Dallas with advice: send fruit
and flowers to Virginia? The President watched you thank me so
graciously! You were the future First Lady, he the President, I
"The angel with the time machine"?
You are, he is, and Ann is, was, will be, with Marybeth
her Chief of Staff and that other guy, too. That other kid I
hung around with, who loved you? (I had to knock him a couple of
times to keep him away from you.) That kid is Steven Spielberg,
now.
You are Princess Leah Organa of Alderon.
Remember my report. Steve drove off 20 hoodlums while we
were canvassing? Ann rescued us? You objected to the rescue
and plan to return? Hear your own words as the imprisoned Star
Wars princess objecting to her rescue. She walks your walk. She
talks your talk. My Princess!
Hillary. You ain't the Princess for nuthin'! Everything
in you is good. Please don't be your cynical self for a few
seconds. You are a wonderful woman, an inspiration to
generations. Trust your instincts, Princess. Listen to the
Force!
Your friend in time,
Butha
Ross C. "Bubba" Nicholson
ps Write. Or are you still mad about getting dragged into this?
Forgive and remember.
pps This time I figured out a medical treatment for criminal
behavior. Seems to work, too! no pubs. but see Brit. J. Derm.
111:623 (1984). Oh and I'm a medical student, 3rd year.
USA
32
STATE
SAVE
YOUR VISION
05 FEB
WEEK
1996
NANCY HERNREICH
DEPUTY ASSISTANT TO THE PRESIDENT
FOR SCHEDULING AND APPOINTMENTS
1600 PENNSYLVANIA AVENUE
WASHINGTON, D.C. 20500
I
DETERMINED TO BE AN ADMINSTRATIVE
MARKING Per E.O. 12958 as amended, Sec. 3.3 (c)
PERSONAL
Initials: 10B
Date 11/15/13
THE WHITE HOUSE
February 28, 1996
Gloria Norris
Gloria Norris Books
133 West 72nd Street
Suite 70Y
New York, New York 10023
Dear Ms. Norris:
Thank you for sending me The Seasons of Women. I
look forward to reading it and appreciate your generosity and
thoughtfulness.
With kind regards, I am
Sincerely yours,
Hillary Hillary Rodham Rolbam Clinton Clenton
bee sift mint sift wint
Glona Norns
Gloria Norris Books
133 west 72ⁿᵈˢᵗ.
Suite 704
New york, NY 10023
(212)874.9204
do TY for book
the that we
I
The seasons wowen
PHOTOCOPY
HRC HANDWRITING
Withdrawal/Redaction Marker
Clinton Library
DOCUMENT NO.
SUBJECT/TITLE
DATE
RESTRICTION
AND TYPE
005. letter
From: Helen Walton, To: Hillary (2 pages)
Jan
Personal Misfile
COLLECTION:
Clinton Presidential Records
First Lady's Office
Pam Cicetti
OA/Box Number: 10598
FOLDER TITLE:
HRC - 1996 Personal - N
2014-0159-S
sb244
RESTRICTION CODES
Presidential Records Act - |44 U.S.C. 2204(a)]
Freedom of Information Act - 15 U.S.C. 552(b)]
P1 National Security Classified Information [(a)(1) of the PRA]
b(1) National security classified information |(b)(1) of the FOIA]
P2 Relating to the appointment to Federal office |(a)(2) of the PRA]
b(2) Release would disclose internal personnel rules and practices of
P3 Release would violate a Federal statute [(a)(3) of the PRA]
an agency |(b)(2) of the FOIA]
P4 Release would disclose trade secrets or confidential commercial or
b(3) Release would violate a Federal statute [(b)(3) of the FOIA]
financial information [(a)(4) of the PRAJ
b(4) Release would disclose trade secrets or confidential or financial
P5 Release would disclose confidential advice between the President
information ((b)(4) of the FOIA]
and his advisors, or between such advisors |a)(5) of the PRA|
b(6) Release would constitute a clearly unwarranted invasion of
P6 Release would constitute a clearly unwarranted invasion of
personal privacy |(b)(6) of the FOIA]
personal privacy [(a)(6) of the PRA]
b(7) Release would disclose information compiled for law enforcement
purposes |(b)(7) of the FOIA]
C. Closed in accordance with restrictions contained in donor's deed
b(8) Release would disclose information concerning the regulation of
of gift.
financial institutions |(b)(8) of the FOIA]
PRM. Personal record misfile defined in accordance with 44 U.S.C.
b(9) Release would disclose geological or geophysical information
2201(3).
concerning wells |(b)(9) of the FOIA]
RR. Document will be reviewed upon request.
ALLERGY &
THE IgE ASTHMA CENTER
Talal M. Nsouli, M.D., F.A.C.A.A.I.
*
Clinical A. Professor of Pediatrics-Allergy/Immunology (GUMC)
BURKE ALLERGY IgE & ASTHMA CENTER
*
Fellow American College of Allergy. Asthma & Immunology (SC)
THE
WASHINGTON DC
BURKE VIRGINIA
The Watergate Allergy & Asthma Ctr.
The Burke Allergy & Asthma Ctr.
Watergate Office Building
9520 Burke Road
2600 Virginia Ave., N.W., Ste. 216
Burke, Virginia 22015
Washington, DC 20037
(703) 425-8616
(202) 342-1984
2/25/96
DETERMINED TO BE AN
ADMINISTRATIVE MARKING
INITIALS: ADB DATE: 11/15/13
Dear MRS. Acciton,
Susan and of would like to thank you
Very much fu the beautiful and very degantly
framed lithography of the Blue Room that
you have seat to Jus.
Your personal letter was the most
wonderful and puperb gift! We admite
really are the best first Lady we ever had !
all your standing accouplish ements. Your
Thank you fu your Kind writating tothe Christmas
Your friend shipuess shighly appreciated.
party that We greatly enjoyed. President Please give my/our
to the and to Deah
bless yeu!
Abalal sinarely. and Susay Msouhing
Fax: (202) 342-1855
Fax: (703) 425-8743
ALLERGY &
INCOMATE THE IgE ASTHMA CENTER
Talal M. Nsouli, M.D., F.A.C.A.A.I.
*
Clinical A. Professor of Pediatrics-Allergy/Immunology (GUMC)
BURKE THE ALLERGY & IgE & ASTHMA CENTER
*
Fellow American College of Allergy, Asthma & Immunology (SC)
WASHINGTON DC
BURKE. VIRGINIA
The Watergate Allergy & Asthma Ctr.
The Burke Allergy & Asthma Ctr.
Watergate Office Building
9520 Burke Road
2600 Virginia Ave., N.W., Ste. 216
2/25/96
Burke, Virginia 22015
Washington, DC 20037
(703) 425-8616
(202) 342-1984
Dear President Chirton,
My wife Susan and I would like to express
Couk extreme thanks for the Mice gift you have
sent to us! Your friend shipmess & highlyappresiated
I would like to congratulate you ou your
autstand ing and most eloquent Shate of the Union
add us that you delivered Jan. 1996. YouR voice,
your tone, and your content were all sensational,
supub, manificent and most outst and
booklet of you historic speech.
Twould guately appreciate to receive au autographed
We are very proud of yourred your superb
prin the pallen season. God bless you!
me know. to Yam Coo king forward to seeing soon
accomplisheenents. If you need anything please let
Suncerely
Talal Nsachi
Fax: (202) 342-1855
Fax: (703) 425-8743
Hope you have a
Merry Christmas
and a Happy new year!
Best Wishes,
Talal and Susan Nsoxli
-
DETERMINED TO BE AN ADMINSTRATIVE
MARKING Per E.O. 12958 as amended, Sec. 3.3 (c)
Initials: ADB Date 11/15/13
THE WHITE HOUSE
January 31, 1996
Mike Niles
1128 Morraine View Drive
Madison, Wisconsin 53719
Dear Mike:
Thank you for your very thoughtful expression of
support. Wherever I went on my recent book tour, I was
encouraged by the many people I met who care about a better
future for our children and our country and whose attention
will not be diverted from these goals. I will continue to draw
strength and optimism from them and from your friendship.
With gratitude and warm regards, I remain
Sincerely yours,
Hillary Hillary Rodham Clinton
I am to happy for
you and July
VIP
American NEWSPAPER
USA
THE
FREEDOM FORUM
ALLEN H. NEUHARTH
FOUNDER/USA TODAY
TODAY
FREE PRESS. FREE SPEECH. FREE SPIRIT.
CHAIRMAN/THE FREEDOM FORUM
NO T IN THE USA READERS
DETERMINED TO BE AN
May 24, 1996
ADMINISTRATIVE MARKING
INITIALS: SWB DATE: 11/15/13
First Lady Hillary Rodham Clinton
The White House
1600 Pennsylvania Avenue, NW
Washington, DC 20500
Dear Mrs. Clinton:
My warmest thanks for your participation in the dedication ceremony for the Journalists
Memorial.
Your remarks were perfectly in tune with the intent and symbolism of the memorial --
comparing the strengths of the steel and the clarity of the glass to the work of journalists. Your
comments struck the right cord with all and many of the family members commented after the
ceremony how deeply moved they were by your attendance and your remarks.
Thanks for working this into a crowded schedule.
Admiringly,
Allen al Venhauts H. Neuharth
sk
1101 WILSON BOULEVARD
300 SOUTH ATLANTIC AVENUE
ARLINGTON, VIRGINIA 22209
COCOA BEACH, FLORIDA 32931
TEL: 703-284-2890
FAX:703-522-4691
TEL: 407-783-3335
FAX: 407-783-9041
Withdrawal/Redaction Marker
Clinton Library
DOCUMENT NO.
SUBJECT/TITLE
DATE
RESTRICTION
AND TYPE
006. letter
From: Hillary Clinton, To: Tom and Carol Nicklaus (2 pages)
5/31/96
Personal Misfile
COLLECTION:
Clinton Presidential Records
First Lady's Office
Pam Cicetti
OA/Box Number: 10598
FOLDER TITLE:
HRC - 1996 Personal - N
2014-0159-S
sb244
RESTRICTION CODES
Presidential Records Act - |44 U.S.C. 2204(a)]
Freedom of Information Act - 15 U.S.C. 552(b)]
P1 National Security Classified Information [(a)(1) of the PRA]
b(1) National security classified information |(b)(1) of the FOIA]
P2 Relating to the appointment to Federal office |(a)(2) of the PRA]
b(2) Release would disclose internal personnel rules and practices of
P3 Release would violate a Federal statute |(a)(3) of the PRA]
an agency |(b)(2) of the FOIA]
P4 Release would disclose trade secrets or confidential commercial or
b(3) Release would violate a Federal statute |(b)(3) of the FOIA]
financial information |(a)(4) of the PRAJ
b(4) Release would disclose trade secrets or confidential or financial
P5 Release would disclose confidential advice between the President
information [(b)(4) of the FOIA]
and his advisors, or between such advisors [a)(5) of the PRA|
b(6) Release would constitute a clearly unwarranted invasion of
P6 Release would constitute a clearly unwarranted invasion of
personal privacy [(b)(6) of the FOIA]
personal privacy [(a)(6) of the PRA]
b(7) Release would disclose information compiled for law enforcement
purposes [(b)(7) of the FOIA]
C. Closed in accordance with restrictions contained in donor's deed
b(8) Release would disclose information concerning the regulation of
of gift.
financial institutions |(b)(8) of the FOIA|
PRM. Personal record misfile defined in accordance with 44 U.S.C.
b(9) Release would disclose geological or geophysical information
2201(3).
concerning wells |(b)(9) of the FOIA]
RR. Document will be reviewed upon request.